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DEPARTMENT OF HEALTH AND HUMAN SERVICES 
CENTERS FOR DISEASE CONTROL AND PREVENTION 
National Center for Environmental Health/ 
Agency for Toxic Substances and Disease Registry 
Lead Poisoning Prevention Branch 
ADVISORY COMMITTEE ON
CHILDHOOD LEAD POISONING PREVENTION
October 21-22, 2009 
Washington, DC 
DRAFT Minutes of the Meeting
The Department of Health and Human Services (HHS) and the Centers for Disease Control and
Prevention (CDC), National Center for Environmental Health/Agency for Toxic Substances and 
Disease Registry (NCEH/ATSDR), Lead Poisoning Prevention Branch (LPPB) convened a
meeting of the Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP).  The
proceedings were held on October 21-22, 2009 at the Four Points by Sheraton Hotel in
Washington, DC.
Opening Session 
Dr. George Rhoads, Chair of ACCLPP, called the meeting to order at 9:00 a.m. on October 21, 
2009. He welcomed the attendees to the proceedings and opened the floor for introductions. 
The list of participants is appended to the minutes as Attachment 1. 
Dr. Rhoads announced that voting members with a real or perceived conflict of interest related 
to any item on the October 21-22, 2009 ACCLPP agenda would be responsible for identifying
these issues and recusing themselves from voting on these topics or participating in these
discussions.
Dr. Sharunda Buchanan, Director of the Division of Emergency and Environmental Health
Services at CDC, thanked the ACCLPP members for their continued commitment, dedication 
and contributions to childhood lead poisoning prevention.  She also expressed her appreciation
to ACCLPP for undertaking a new role in providing solid guidance and recommendations to
LPPB during its transition to healthy homes initiatives. 
Dr. Buchanan confirmed that Dr. Mary Jean Brown, Designated Federal Official of ACCLPP and
Chief of LPPB, provides regular updates to CDC on ACCLPP’s activities and accomplishments.
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She was pleased to note that ACCLPP’s efforts over time have resulted in greatly advancing the
science and practice of childhood lead poisoning prevention.  Dr Buchanan concluded her
opening remarks by inviting the ACCLPP members to attend CDC’s National Environmental
Public Health Conference on October 26-28, 2009 in Atlanta, Georgia. 
Overview of the DC Department of the Environment 
Childhood Lead Poisoning Prevention Program 
Mr. Pierre Erville, Esq., Associate Director of the District Department of the Environment 
(DDOE) Lead and Healthy Housing Division, explained that DC is a high-risk jurisdiction in
terms of lead poisoning.  Of ~275,000 housing units in DC, ~25,000 are vacant.  Of DC’s entire
housing stock, nearly 90% is pre-1980 construction.  Of this housing stock, ~51% is pre-1950 
construction.  Of all households in DC, >40% have an annual income <$35,000. Of ~42,000 
children <6 years of age who live in DC, at least 66% are eligible for or enrolled in Medicaid.
The DC screening law requires universal screening of all children 1 and 2 years of age.
Children must be screened between 6-14 months of age for the first test and 22-26 months of 
age for the second test.  Children >26 months of age who were not previously screened must
receive a blood lead test before reaching 72 months of age and enrolling in a daycare or school. 
However, parents of school-age children can opt-out of this requirement for religious reasons.
DDOE’s 2005-2008 screening data showed that screening rates ranged from 55% in 2005 to
46% in 2007 for children 12-23 months of age and from 55% in 2005 to 42% in 2007 for children 
24-35 months of age. An additional 3,704 children 0-11 months of age were screened in DC in
2005 and 2007 and several thousand more children 36-71 months of age were screened 
annually as well. 
DDOE’s 2007-2008 elevated blood lead level (EBLL) data showed that 170 cases of EBLLs >10 
µg/dL were reported in 2007 and 2008.  The rate of EBLLs >10 µg/dL as a percentage of
children tested was 0.68% in 2007 and 0.59% in 2008.  In 2007 and 2008, 1,367 cases of BLLs 
5-9 µg/dL were reported. The rate of BLLs 5-9 µg/dL as a percentage of children tested was 
6.15% in 2007 and 4.14% in 2008.
Legislation was enacted that transferred authority of the DC Lead Poisoning Prevention
Program (LPPP) from the health department to DDOE beginning on October 1, 2008.  DDOE 
now has responsibility for the bulk of DC’s LPPP components, including enforcement,
permitting, accreditation, certification and the Childhood Lead Poisoning Prevention Program
(CLPPP). Under this law, the DC mayor charged DDOE with coordinating DC’s lead poisoning
prevention strategy, chairing quarterly meetings of an Interagency Lead Task Force, and
staffing meetings of the Lead and Healthy Housing Advisory Committee. 
The DDOE Lead and Healthy Housing Division conducts lead poisoning prevention activities 
under two branches. The CLPPP and Healthy Housing Branch is supported by funding from
CDC and local resources.  Key activities of the branch are highlighted as follows.  To promote 
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lead screening and fill screening gaps, DDOE has a regular presence and makes presentations
at a variety of outreach settings, such as meetings of the Mexico and El Salvador Consulates,
health fairs, and events in Chinatown and the broader Asian community.
DDOE also uses the National Nursing Centers Consortium (also known as Lead Safe DC), the
local chapter of the American Academy of Pediatrics, and the Lead and Healthy Housing 
Advisory Committee to provide education on the DC lead law, fill screening gaps and further 
promote lead screening to pediatricians, social workers, nurses, daycare centers and
community organizations. 
To collect and analyze data, DDOE sends annual reminder letters to laboratories to submit
blood lead test results; uses DDOE staff, the Office of the Chief Technology Officer and an
epidemiologist to refine and analyze data; and provides data to the Department of Health Public 
Health Tracking Advisory Committee as requested.  DDOE also has expressed a strong desire
to join the Adult Blood Lead Epidemiologic and Surveillance (ABLES) Program. 
To manage cases, DDOE uses two nurses and three phlebotomists to investigate all children 
reported with BLLs >10 µg/dL.  DDOE’s protocol requires case managers to frequently interact
with the family of each case, update the Leadtrax database, use the Lead Case Tracker
database to check the status of actions taken to eliminate hazards in the home, and regularly
communicate with providers via facsimile.  The Lead Case Tracker database houses all 
information on a case in one location, allows case managers to monitor progress, and sends e-
mail alerts to case managers on significant developments. 
To integrate healthy homes components into the Lead Program, DDOE is collaborating with the
Air Quality Division to provide radon kits for testing homes and is partnering with Fire and
Emergency Medical Services to install combination smoke/carbon monoxide detectors in homes
at no charge. DDOE is leveraging its membership on the DC Control Asthma Now Steering
Committee to further integrate healthy homes components into the Lead Program and also is 
actively seeking additional resources. 
To conduct primary prevention activities, DDOE has a strong focus in four areas:  children with
BLLs 5-9 µg/dL, expectant mothers, proactive identification and elimination of lead hazards, and
education to contractors on lead safe work practices (LSWP) under a joint pilot project with the
U.S. Environmental Protection Agency (EPA). DDOE awarded a subcontract to Lead Safe DC 
to visit the homes of children with BLLs 5-9 µg/dL, provide one-on-one education and cleaning
demonstrations to these families, collect dust samples, and perform HEPA vacuum cleaning in
response to elevated dust wipe results.  DDOE partnered with the DC Department of Health, 
Women, Infants and Children (WIC) Program, and Healthy Start Program to provide the same 
primary prevention interventions in the homes of expectant mothers.
Lead Safe DC visited 76 households of children with BLLs 5-9 µg/dL from September 1, 2008­
August 31, 2009.  Of these households, 25 were non-English speaking and 76% had dust lead
levels near or greater than the hazard level. These data showed that the homes of children with 
BLLs 5-9 µg/dL were at significant risk of containing elevated levels of lead in household dust.
Lead Safe DC also visited 179 households with expectant mothers during the same time period.
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Of these households, 9 were non-English speaking and 13% had dust lead levels nearer or
greater than the hazard level. 
DC’s new lead law has allowed DDOE to undertake proactive hazard identification and control 
in large multifamily properties and geographic locations that are “hot spots” for lead poisoning in
DC. DDOE will initiate a pilot project with the Weatherization Program to conduct dust testing
after window replacements and other weatherization activities have been completed in 100 
homes built prior to 1940.  DDOE plans to require clearance of all weatherization activities if 
dust lead levels in the 100 pilot homes are found to be elevated.  DDOE also will launch a
project early in 2010 to analyze soil in community gardens owned by the DC government.
DDOE intends to abate the soil if the levels are found to be elevated. 
In March 2009, DC enacted one of the most promising, innovative and progressive lead laws in
the country. The legislation presumes that all pre-1978 properties contain lead paint, provides
DDOE with broad authority to inspect and issue orders, and requires the use of LSWP during
renovation or abatement of all pre-1978 properties.  DDOE’s broad authority covers interim 
controls or abatement, relocation of families, cost reimbursement, penalties and referral of
cases to the attorney general when necessary.
DC’s new lead law extends far beyond federal disclosure requirements.  The clearance at
turnover provisions were written in three phases. Phase 1 was recently enacted and now 
requires property owners to produce clearance reports issued within the previous 12 months to 
prospective new occupants who are <6 years of age or pregnant.  In phase 2, property owners
will be required to produce clearance reports for all pre-1950 housing to all new occupants 
based on the results of phase 1 one year later.  In phase 3, property owners will be required to 
produce clearance reports for all pre-1978 housing to all new occupants based on the results of
phase 2 one year later.  DC’s new lead law was written with all of the same federal disclosure
requirements and is enforceable at the local level. 
DDOE’s Compliance and Enforcement Branch is supported by funding from EPA and local 
resources.  Key activities of the branch are highlighted as follows.  The branch issues 
abatement permits, accredits training providers, certifies lead disciplines, uses a partnership 
with the Child and Family Services Agency (CFSA) to inspect prospective foster care homes for 
lead hazards, provide compliance assistance, and enforces DC’s lead laws.  As of October 
2009, DDOE was given responsibility for conducting up to 190 risk assessments in the current 
fiscal year in the homes of prospective foster care parents.  If hazards are identified in these 
homes, DDOE will issue orders, require clearance and refer cases to the DC Lead Hazard
Control Grant Program.
To provide assistance with compliance, DDOE developed and posted a reader-friendly version
of the DC lead law on its website and also distributed the law to training providers, abatement 
contractors, private-sector inspectors, risk assessors, and major property managers and
owners. DDOE held one-on-one meetings with contractors, affected tenants and property 
managers to further explain the lead law.  DDOE recently made a presentation to property 
owners and managers who are members of a large apartment owner association.
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To enforce the DC lead law, DDOE collaborates with EPA on disclosure enforcement
requirements and the U.S. Department of Housing and Urban Development (HUD) on the Lead 
Disclosure Rule.  DDOE receives support from the Office of the Attorney General and the Office
of the Tenant Advocate to enforce EBLL cases and undertake proactive hazard identification 
and control.
DDOE’s EBLL enforcement protocol requires an environmental investigation that includes water
sampling, x-ray fluorescence (XRF) and environmental sampling of dust and soil.  Property
owners are given 30 days to comply with an EBLL enforcement order, but DDOE will issue an
extension to the deadline if the owner demonstrates a good faith effort in abating the property.
DDOE refers non-compliant property owners to the HUD Lead Hazard Control Grant Program 
and the Office of the Attorney General. 
After the DC lead law was enacted in March 2009, DDOE closely collaborated with the Office of 
the Tenant Advocate to identify and send letters to major property owners and managers in DC 
wards at highest risk for lead poisoning.  DDOE plans to expand and more effectively target its 
proactive enforcement efforts in the future by using geographic information system (GIS) 
indicators to identify specific jurisdictions that are “hot spots” for EBLLs.  The GIS indicators also
will be used to pinpoint neighborhoods with old housing stock, a large number of code violations 
and nuisance properties with visibility in the public right-of-way. 
DDOE’s dissemination of the DC lead law letter resulted in a 100% cooperation rate among
property owners of 18 pre-1978 large multi-family properties containing 3,747 units.  The 
owners hired contractors to inspect, assess risks and evaluate lead hazards in each property 
and unit. All of the property owners will submit copies of the hazard evaluation reports to
DDOE. DDOE is currently entering the hazard evaluation reports into a database to monitor the
status of lead hazards within the properties over time. 
DDOE’s current activities include modifying its strategic plan with a stronger focus on the 
elimination of lead poisoning and the promotion of healthy housing; developing a Medicaid 
reimbursement system; applying for authority from EPA to conduct a Renovation, Repair and 
Painting Program; creating a new partnership with the Legal Aid of DC if the EPA grant proposal 
is funded; and applying for a HUD Healthy Housing Grant. 
DDOE hopes and intends to conduct a number of activities in the future.  DDOE will improve
and update its website with more targeted, visible and effective outreach components.  DDOE 
hopes to become an ABLES jurisdiction; train code inspectors at the Department of Consumer 
and Regulatory Affairs; and provide LeadCare II units to health clinics to increase lead
screening rates if the Health Resources and Services Administration awards DDOE’s grant 
proposal for Title V funding. 
DDOE hopes to lead the coordination and collaboration among all relevant DC agencies and a
range of community partners.  DDOE will strengthen its relationship with the DC Medicaid 
Agency because the vast majority of children <6 years of age who live in DC are Medicaid-
eligible. DDOE hopes to fully fund financial assistance programs for property owners to abate 
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identified lead hazards.  DDOE hopes to position DC as a model jurisdiction for the country that 
fully focuses on lead hazard elimination and ensures its residents live in healthy homes. 
 
ACCLPP applauded DDOE on developing an extremely innovative Lead Poisoning Prevention 
Program, advancing DC’s progressive lead law and serving as an example for the nation.  The 
members were particularly impressed by DDOE’s primary prevention focus areas of children 
with BLLs 5-9 µg/dL and pregnant women; leadership in code enforcement; collaboration with 
the Weatherization Program to pilot the clearance project for dust testing; and the DC legislation 
that presumes all pre-1978 properties contain lead paint. 
 
Several ACCLPP members expressed a strong interest in incorporating DDOE’s primary 
prevention focus areas into all CDC-funded CLPPPs and encouraging other jurisdictions 
throughout the country to adopt the presumption that all pre-1978 properties contain lead paint. 
 
The ACCLPP members made several comments and suggestions for DDOE to consider in 
further implementation of its lead poisoning prevention and healthy housing activities. 
 
 	 DDOE should use its primary prevention focus area of children with BLLs 5-9 µg/dL to 
conduct research to determine the effectiveness of different interventions in various 
homes. The study should be designed with a comparison group.  This research would 
play a key role in filling existing data gaps and identifying evidence-based interventions 
that are effective in reducing BLLs 5-9 µg/dL in children. 
 	 DDOE should recognize the problems associated with office-based lead screening.  
Providers are less likely to report results to health departments with office-based lead 
screening. Moreover, the allowed variability of the LeadCare II instrument is +6 µg/dL, 
but its performance is better than this limit. DDOE should develop a mechanism to 
ensure providers can easily report screening results from their offices.  DDOE also 
should create protocols to ensure samples taken in the office are carefully monitored, 
handled and processed. 
 	 DDOE should expand its lead screening promotion efforts to outreach to socioeconomic 
groups other than low-income and Medicaid populations.  Most notably, affluent families 
who purchase old homes also could benefit from education on lead risks and hazards to 
young children and pregnant women during the renovation of these properties. 
 
Dr. Brown congratulated DDOE on its new authority to enforce lead safety requirements in units 
before children achieve qualifying BLLs that trigger services.  She pointed out an Epidemic 
Intelligence Service Officer would be available to LPPB for the next two years and could assist 
DDOE in designing ACCLPP’s proposed study of lowering BLLs 5-9 µg/dL in children.  
 
 Update on CDC’s Lead Poisoning Prevention and Healthy Homes Activities 
 
Dr. Brown covered the following areas in her update. On August 7, 2009, CDC published 
Recommendations for Blood Lead Screening of Medicaid-Eligible Children Aged 1-5 Years: An 
Updated Approach to Targeting a Group at High Risk.  The paper recommended that state and 
local officials target screening to specific groups of children at higher risk for EBLLs in their 
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areas. The paper also supported targeted rather than universal screening because recent data
indicate that BLLs are decreasing among children in low-income families and the EBLL disparity 
between Medicaid-eligible and non-Medicaid-eligible children is diminishing. 
CDC developed a Healthcare Effectiveness Data and Information Set (HEDIS) measure for 
managed care organizations and healthcare providers to determine whether their Medicaid-
enrolled patients 2 years of age received a blood lead test.  The HEDIS measure will determine
whether their Medicaid-enrolled patients have received a blood lead test by 2 years of age.  The 
review will be piggybacked on a similar measure of immunization status.  Several CLPPPs have
successfully linked Medicaid encounter data and blood lead testing data to distribute report
cards or letters to healthcare providers regarding their individual performance in screening
Medicaid-enrolled children. CDC expects the first provider-based data set from the HEDIS 
measure to be available early in 2010. 
CDC sponsored a webinar with state and local health departments and also had discussions 
with advocates to clarify the updated recommendations on blood lead screening of Medicaid-
enrolled children.  CDC and the Centers for Medicare and Medicaid Services (CMS) recently
distributed a joint letter to state Medicaid Directors and regional CMS Coordinators to explain
that a “targeted screening plan” must be supported by strong data. CDC also is urging its 
funded CLPPPs to adopt the HEDIS measure. 
CDC’s next steps in this initiative will be to update the State Medicaid Manual and collaborate
with CMS to develop a joint framework to evaluate targeted screening plans submitted by
jurisdictions.  However, the current obligation to conduct blood lead testing of Medicaid-enrolled
children 1 and 2 years of age will remain in effect until the State Medicaid Manual is revised. 
CDC is continuing its efforts to promote Medicaid reimbursement of blood lead testing 
conducted by WIC programs.  To support this initiative, CDC is compiling and will provide
Medicaid Directors and regional CMS Coordinators with case studies of WIC programs that 
have implemented successful and creative strategies in conducting blood lead screening of
Medicaid-enrolled children.  The U.S. Department of Agriculture is coordinating with CDC and 
CMS in the effort to secure Medicaid reimbursement for blood lead screening conducted by WIC
programs. 
Dr. Brown reported on the status of three Healthy People 2010 objectives and proposed Healthy 
People 2020 objectives that are relevant to lead poisoning prevention and healthy homes.  One, 
the current 2010 objective is to eliminate EBLLs in children with a target of 0%.  The proposed
2020 objective will be to reduce BLLs in children by focusing on two sub-objectives: eliminate 
EBLLs in children and reduce the mean BLL in children. HHS’s justification for the proposed
2020 objective is summarized as follows.  The National Health and Nutritional Examination 
Survey (NHANES) is the data source for the 2010 objective, but does not have sufficient 
resolution to accurately provide population-based estimates of the number of children with
EBLLs due to the small sample size of children <6 years of age. 
NHANES has sufficient data to estimate the geometric mean of BLLs nationally and for targeted 
sub-populations. The addition of sub-objective 2, in combination with sub-objective 1, focuses 
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attention on reducing the central measure of BLLs in both the national population and sub-
populations.  Sub-objective 2 also addresses historic disparities in the geometric mean of BLLs
in sub-populations and will help to focus attention on sub-populations with BLLs above the 
decreasing overall population mean. 
Two, the current 2010 objective is to increase the proportion of persons living in pre-1950 
housing that have been tested for the presence of lead-based paint.  The proposed 2020
objective will be to (1) increase the proportion of pre-1970 housing that has been tested for the 
presence of lead-based paint, lead in dust or lead in soil and (2) decrease the number of U.S.
homes identified with lead-based paint, dust lead hazards or soil lead hazards. CDC’s next
steps for the proposed 2020 objective will be to solicit public comment through the Federal 
Register and convene a series of public meetings beginning with Kansas City the week of 
October 19, 2009. 
Three, the current 2010 objective is to reduce indoor allergen levels with the following targets:
(1) Group I dust mite allergens exceeding 2 µg/g of dust in the bed, (2) Group II dust mite 
allergens exceeding 10 µg/g of dust in the bed, and (3) German cockroach allergens exceeding 
0.1 unit per gram of dust in the bed.  The proposed 2020 objective will be to reduce indoor
allergen levels in cockroaches and mice. 
CDC’s justification for the proposed 2020 objective is summarized as follows.  The most recent 
American Healthy Homes Survey did not collect samples from beds.  Health-based threshold
levels were dropped due to their uncertainty.  Dust mite allergens were dropped due to their 
wide distribution both geographically and within homes. The possibility exists that these
allergens could be endemic to some regions of the country.  Cost-effective mitigation strategies 
for reducing whole-house levels need further development.
Dr. Brown summarized preliminary findings of two studies that were recently completed as a
result of lead poisoning investigations.  The Indiana State Department of Public Health 
investigated a cluster of unexplained lead poisoning cases among ~100 Burmese refugee 
children in Fort Wayne, Indiana.  In general, the study showed that children who used Thanakha
or Daw Tway were more likely to have EBLLs.  In particular, children <1 year of age who used
Daw Tway had an extremely high adjusted mean BLL of 24.6 µg/dL and children >1 year of age 
who used Daw Tway also had a significant adjusted mean BLL of 10.7 µg/dL. 
Daw Tway is a traditional medicine that is administered to infants as a digestive aid.  The
product was detected in four of the Fort Wayne cases and contained 480-560 ppm lead.  Daw 
Tway was imported into the country by travelers from Southeast Asia, but its availability at local 
markets in Fort Wayne is unknown. 
CDC investigated a cluster of lead poisoning cases among 30 Burmese refugee children <2 
years of age in Tak Province Camps in Thailand.  The most significant risk factors for lead
poisoning in the study population were exposure to car batteries, iron deficiency and mouthing
of non-foods. CDC issued several recommendations based on results of the study.  Car battery 
exposure should be minimized or eliminated through education and administration of a
household utilization survey.  Micronutrient deficiencies of iron and calcium should be 
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addressed.  Screening of all refugee children should be continued in accordance with CDC 
guidelines.
Community education should be conducted in refugee camps and safe housing should be
provided. Continuity of care to Burmese refugee children should be enhanced by improving 
coordination both domestically and overseas.  Follow-up testing should be conducted in
Thailand and state Refugee Health Coordinators should be notified of U.S. arrivals.  Domestic 
results should continue to be shared because no method has been established to date to collect 
health information on domestic refugee children.
Dr. Brown announced that CDC, EPA and HUD jointly sponsored a contest for high school 
students to develop lead poisoning prevention videos.  The videos would be broadcast on You
Tube, but the agencies also would develop a strategy to widely distribute the videos through 
other venues. An awards ceremony would be held during the 2009 National Environmental
Public Health Conference to present college scholarships to the first-, second- and third-place
winners. The videos of the three winners were presented to ACCLPP during the meeting. 
Dr. Brown devoted the remainder of her update to CDC’s healthy homes activities.  On June 8,
2009, the Surgeon General issued a “Call to Action to Promote Healthy Homes” to focus 
attention on the public health impact of homes and outline a series of coordinated actions to
improve the health of the nation’s homes.  The Call to Action outlines a society-wide approach 
to healthy homes that will result in the greatest possible public health impact and reduce
disparities in the availability of healthy, safe, affordable, accessible and environmentally-friendly 
homes. The Call to Action has received a great deal of positive attention, interest and energy. 
The Call to Action is based on three overarching premises.  First, no one is immune from the 
effects of unhealthy and unsafe homes.  This guiding principle focuses on indoor air quality,
home design and resident behaviors, and accessibility and affordability of housing.  Second,
healthy homes lead to healthier lives. Third, communities, individuals, organizations, healthcare
providers and government agencies can take actions to ensure healthy homes.  CDC hopes 
that an interagency effort can be launched over the next two years to achieve the goal of testing
building materials before their placement in housing.
An Interagency Healthy Homes Task Force was established with CDC, EPA, HUD, the U.S.
Department of Energy, U.S. Department of Agriculture, Office of the Surgeon General, and
National Institute of Standards of Technology. The purpose of the Task Force is three-fold.
First, consensus will be achieved on the development of a “National Strategy to Promote 
Healthy Homes” that delivers safe and healthy housing for all citizens through collaborative 
efforts of federal, non-federal and private-sector leaders.  Actions that federal agencies can take
to advance the National Strategy are expected to be released by the end of November 2009. 
Second, federal agencies will identify and leverage opportunities to eliminate barriers that
impede collaboration and complicate providing assistance to persons in need of federal funding. 
For example, the federal partners are exploring creative strategies to develop criteria across 
agencies and jurisdictions for communities to apply for federal and state healthy housing
funding in a more consistent and streamlined manner.  Moreover, CDC and HUD are discussing 
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the feasibility of releasing joint notice of funds available (NOFAs) for healthy housing projects. 
Third, federal efforts will be joined with key non-federal and private-sector stakeholders to
implement a rigorous healthy homes agenda at the community level.
The HHS and HUD Secretaries have been meeting to explore interagency strategies that could 
be developed and implemented to address three important housing agendas:  homelessness;
funding streams for elderly Americans and persons with disabilities to remain in their homes; 
and livable and sustainable communities with a health-promoting built environment at the macro
level and healthy homes at the micro level. CDC is serving as the lead agency for these 
activities for HHS.  Dr. Brown confirmed that she would provide an update to ACCLPP on
initiatives under these housing agendas during a future meeting. 
Dr. Brown highlighted awards CDC recently issued with its first healthy homes NOFA.  The
$600,000 NOFA will support six planning grants over the next two years.  The six grantees will 
use the funding to develop a blueprint for healthy homes activities in their respective 
jurisdictions.  Because 64 applications were submitted, CDC used specific criteria (i.e., diversity 
in geographic locations and types of institutions) to make the awards. 
Impact Assessment, Inc., agent for the California Department of Public Health Division of
Environmental and Occupational Disease Control, was awarded $109,890 to assist local 
agencies with investigating and resolving hazards in the home and also to develop assessment,
enforcement and compliance tools designed to help local housing and building agencies in all 
61 jurisdictions in the state.  During the two-year project period, California will measure trends 
and changes in health outcomes related to asthma and lead exposure. 
The New York City Department of Health and Mental Hygiene was awarded $110,000 to 
conduct evaluations of existing activities to reduce home health hazards, create a healthy 
homes action plan, and consolidate and analyze basic healthy homes information.  The action
plan will need to be adopted by local officials to lead the way in implementation of practices 
determined by the teams. 
Environmental Health Watch in Cuyahoga County, Ohio was awarded $82,095 to develop a 
“Healthy Housing Strategy Alliance” to convene key organizations in health, housing and other 
associated sectors to create and implement a healthy housing plan in conjunction with a broad 
range of additional stakeholders.
The University of Nevada-Las Vegas was awarded $108,300 to conduct two major activities in
years 1 and 2 of the project: (1) develop a plan to coordinate assessment and remediation
activities to address housing-related health hazards and (2) begin conducting assessments and
using remediation tools to reduce hazards known to impact the home environment.
The Oklahoma State Department of Health was awarded $100,000 to administer the Tulsa Safe 
and Healthy Housing Project in Tulsa, Oklahoma with a goal of identifying, analyzing and 
prioritizing specific health and safety hazards found in home environments of the target
population and implementing measures to reduce these hazards.  During the two-year project
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period, Oklahoma will partner with the Children First Program to reduce health hazards found in
~500 homes of clients who live in pre-1950 housing. 
The Rhode Island Department of Health was awarded $109,402 to increase the availability of 
safe, healthy and affordable housing in the state and also to address targeted hazards in high-
risk populations in the cities of Providence and Pawtucket.  During the two-year project period,
Rhode Island will target children who receive medical services at St. Joseph Hospital and
Project Health Providence in Hasbro as well as refugee families and children. 
Dr. Brown is collaborating with the Council of Foundations to identify resources to support some 
of the proposed projects that were not funded under CDC’s healthy homes NOFA.  She
confirmed that over the next six to nine months, CDC would convene its six grantees and 
grantees funded by other agencies to share best practices and lessons learned in developing 
and implementing healthy homes projects.
Dr. Brown concluded her update by announcing that the city of Detroit recently passed a strong
and proactive city ordinance.  The new law is extremely protective of a lead paint abatement
and lead poisoning prevention standard.  The participants joined Dr. Brown in applauding
Detroit’s outstanding accomplishment. 
ACCLPP was extremely impressed by the progress CDC and its federal partners have made
over the past six months in advancing existing activities and developing new projects in the
areas of lead poisoning prevention and healthy homes.  The ACCLPP members made two key 
suggestions for CDC to consider in maintaining this momentum.
First, CDC should encourage its federal partners on the Interagency Healthy Homes Task Force 
to engage the architectural and engineering communities (i.e., the American Institute of 
Architects, National Society of Professional Engineers, and National Institute of Building
Sciences) in activities to impact the future housing stock.  Mr. Steve Hayes is the ACCLPP 
liaison to the American Industrial Hygiene Association and offered to facilitate linkages and
communications between CDC and these organizations. 
Second, CDC and its federal partners should make stronger efforts to urge local agencies to 
collect and submit existing data on rodents, carbon monoxide/smoke detectors, and other 
healthy homes components.  For example, the New York City Department of Health and Mental
Hygiene has used grant funds from the CDC National Environmental Public Health Tracking
Program to gather healthy homes data.  Dr. Jessica Leighton is an ACCLPP member and 
Deputy Commissioner of the New York City health department.  She offered to provide CDC 
with models in which local data from New York City were successfully applied to healthy homes 
projects.
Update by the Educational Intervention Workgroup (EIWG) 
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Dr. Lynn Gardner is an ACCLPP member and chair of EIWG.  She covered the following areas 
in her update. The EIWG members represent ACCLPP, CDC, academic institutions, CDC-
funded CLPPPs, professional associations, community-based organizations, and parents of
lead-poisoned children.  ACCLPP charged EIWG with drafting recommendations to address the
educational intervention needs of children with EBLLs.  Dr. Gardner’s summary of the structure
of the draft educational intervention paper is outlined below.
The preface of the paper will focus on three distinct areas. First, EIWG’s charge will be clearly
defined. Existing evidence on deficits will be compiled.  Parts B and C of the Individual with 
Disabilities Education Act (IDEA) will be reviewed.  Specific action steps that can be taken by
parents, clinicians, educators, community advocates and other groups will be described. 
Second, EIWG’s challenges in fulfilling its charge will be noted.  The number of persons and
groups needed to evaluate and manage the educational needs of lead-poisoned children and
enroll this population into existing educational programs is quite large and will require a
tremendous amount of coordination.  No studies have been conducted and no evidence has 
been produced to demonstrate that educational interventions targeted to children with EBLLs 
are likely to improve children’s academic outcomes compared to EBBL children who do not 
receive educational interventions have greater or lesser efficacy than those targeted to other 
children with developmental disabilities.  However, research opportunities certainly exist in this
area. 
Third, the basis of the recommendations will be outlined.  Clear evidence exists that early 
educational intervention services improve educational and behavioral outcomes for at-risk 
children. Clear evidence exists that an enriched environment for lead-exposed laboratory 
animals improves their ability to learn.  Evidence also exists that EBLLs well below 10 µg/dL are 
associated with educational and behavioral deficits in children. 
The overview of the educational intervention paper will be divided into five sections.  Section 1
of the paper will describe deficits that are known to be associated with EBLLs in children.  The
evidence shows that EBLLs are related to clinical deficits from a cognitive perspective, such as
IQ and visual spatial skills.  The 1995 Spreen, et al. study demonstrated that EBLLs also impact 
executive functions, such as strategic planning, impulse control, organized searching, flexibility 
of thought and action, and self-monitoring of one’s own behavior. 
The evidence shows that EBLLs are related to clinical deficits from a behavioral and social 
conduct perspective, such as restlessness, impulsivity, inattention and aggression. EBLLs also
have been associated with educational deficits in reading, spelling and math, but EIWG is 
continuing to collect and review data in this area.  Constructs that are used to organize learning
profiles of students include attention, temporal-sequential ordering, spatial ordering, memory,
language, neuromotor functions, social cognition, and higher order cognition.  No studies have 
been conducted and no evidence has been produced to demonstrate that educational
interventions targeted to children with EBLLs have greater or lesser efficacy than those targeted
to other children with developmental disabilities. However, research opportunities certainly exist 
in this area.
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Section 2 of the overview will describe assessment tools and clearly define triggers for 
assessment.  Screening tools will be recommended as the first tier of an assessment.  The
paper also will recommend using BLLs >5 µg/dL detected during screening to warrant early 
intervention and enhancement for children <5 years of age and surveillance for specific deficits
for school-age children.  Deficit-specific assessment tools will be recommended as the second
tier of an assessment.
EIWG is continuing to discuss coordination and consistency between recommendations in the 
paper and existing developmental screening requirements.  Assessments require compliance
with IDEA child identification/child find procedures.  In accordance with IDEA Parts B and C
federal regulations, schools are required to assume reponsibility for the location, identification 
and evaluation of all children from birth through 21 years of age who require special education
and related services. All children who are suspected of having a disability and who are in need
of special education are part of the child find process in a school district.  Section 2 also will
provide examples of assessment tools for cognitive, behavioral and educational functions.
Section 3 of the overview will describe educational interventions for children with EBLLs.  Steps 
should be taken to immediately intervene upon identification of BLLs >5 µg/dL to prevent deficits 
by encouraging parent-focused enrichment activities and enrolling children in an Early 
Intervention Program.  Educational and other interventions for deficits will be highlighted in
Section 3, such as reading, math, spelling, speech therapy, physical therapy and nutrition.
Section 3 will describe the three major components of an effective Early Intervention Program: 
(1) parent skill-building and enrichment; (2) direct interaction with the child in a center-based or
home-based model of early childhood education; and (3) well-defined objectives and well-
designed evaluations as recommended by the National Research Council and Institute of
Medicine in 2000. 
Section 4 of the overview will cite laws for educational interventions for children with EBLLs. 
EIWG is currently reviewing existing laws that protect the rights of children with deficits related
to EBLLs and also is identifying gaps in these laws.  EIWG reviewed IDEA Part C that pertains 
to children 0-3 years of age.  The law contemplates, but does not explicitly mention services
based on lead poisoning.  The regulation states that infants and toddlers who experience or
have a condition that most likely would result in developmental delays are eligible for early 
intervention services. Based on this language, EIWG noted that children with EBLLs would fall 
under IDEA Part C. 
EIWG also reviewed IDEA Parts B and C that pertain to autism, emotional disturbance, mental 
retardation, other health impairment, specific learning disabilities, and speech or language 
impairment.  Based on the language in these sections, EIWG noted that children with EBLLs 
would fall under IDEA Parts B and C. 
Section 5 of the overview will describe advocacy steps that communities can take to implement 
the recommendations, advance evidence-based policymaking and advocate for an educational 
intervention research agenda.  EIWG acknowledges the need to widely distribute information to
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parents, educators, physicians and community organizations after the educational intervention
recommendations have been cleared for release.
ACCLPP commended EIWG on its tremendous progress in drafting the educational intervention 
paper over the past six months.  The members made several comments and suggestions for
EIWG to consider in its further development of the document. 
 EIWG should include a description of the New York City model in the educational 
intervention paper. Organizations that receive state funding under contracts with the 
New York City health department to provide early intervention services are held
responsible for conducting blood lead screening of all children who receive these 
services.
 EIWG should consider the difficulties in providing intervention services to older children 
>6 years of age with high BLLs who are already enrolled in school and exhibit learning
disabilities, hyperactivity and other deficits as a result of severe lead poisoning.
 EIWG should include a flowchart in the educational intervention paper to organize the
recommendations.
 EIWG should revise the legal section of the educational intervention paper with 
descriptions of 504 Education Plans and other legal mechanisms.  The provision of early 
intervention services under IDEA is only triggered by the identification of medical 
conditions and might miss a critical group of children. 
 EIWG should include nurses as another target group for the educational intervention 
paper. 
Dr. Brown explained that Chicago, Rhode Island and other jurisdictions are reviewing and
matching school administrative data sets and blood lead test results to determine whether 
children received Head Start or other early intervention services.  Based on the timeline of these 
activities, she noted that EIWG might have an opportunity to include these data in the
educational intervention paper. 
In response to Dr. Rhoads’ question, Dr. Brown confirmed that ACCLPP would have a more
detailed discussion at the next meeting on EIWG’s proposed recommendation to use BLLs >5 
µg/dL to warrant early intervention services.  She emphasized that evidence has not been 
produced to date to demonstrate the effectiveness of an intervention to reduce, for example, a
BLL of 7 µg/dL to 3 µg/dL. 
Update by the Lead in Consumer Products Workgroup (LCPWG) 
Dr. Michael Kosnett is an ACCLPP member and chair of LCPWG.  He introduced a panel of 
two speakers who would make presentations on lead in consumer products to inform ACCLPP’s 
discussion on this issue.




                                                                           
 
 

























Ms. Linda Block is a Coordinator, Lead Risk Assessor and Healthy Homes Specialist at the 
University of North Carolina-Asheville (UNCA) Lead Poisoning Prevention Program (LPPP).
She explained that the North Carolina Department of Environment and Natural Resources has
received funding from CDC since 1997 to support the UNCA LPPP.
The mission of the UNCA LPPP is to proactively promote lead-safe environments for all 
residents of Buncombe and Henderson Counties through public education, home inspections, 
and professional training to healthcare providers, parents, pregnant women, realtors, property
managers and construction contractors.  BLLs >10 µg/dL trigger inspections by North Carolina 
health departments, but the UNCA LPPP has focused on and responded to all childhood BLLs 
5-9 µg/dL since its inception in 1997.
Lead continues to be a concern in the United States.  Lower lead levels are known to be 
harmful. New immigrants and children adopted from foreign countries pose new risks for lead 
throughout the country.  Adults who make lead-containing consumer products increase the risk 
for lead poisoning to children as a result of take-home exposures.  Old homes and household
products continue to serve as significant sources of lead in the United States.  Ms. Block’s 
description of consumer products that continue to be a concern for lead is outlined below. 
Product 1 is brass and brass keys, but most individuals are unaware that these products contain
lead. Most adults and many children possess or handle keys daily without washing their hands
afterwards. Some persons also place keys in their mouths, such as infants who are fascinated
by keys and other shiny or jingly objects.  Although keys are often used as toys for babies and
infants, they are not considered or regulated as a “children’s item.” 
A number of groups are affected by lead exposure from keys, including manufacturers of key 
templates, key cutters, locksmiths and their family members; all persons who handle keys; all 
persons who place keys in their mouths; and disposers of keys.  The 2005 Kondrashov, et al.
study assessed lead exposure risks in six professional locksmiths and six control volunteers. 
The study showed significant elevations in bone lead from past exposure and significant
elevations in blood lead from current exposure. 
Lead levels in keys can exceed 19,500 ppm and are much higher than the allowable limit of lead 
in children’s items. The threshold was decreased to <300 ppm in August 2009 and will be 
further reduced to <100 ppm beginning in August 2011.  The American Academy of Pediatrics 
has proposed an allowable limit of lead in children’s items of <40 ppm. Voluntary standard 
organizations have established <90 ppm as the amount of lead that can migrate from toys.
California Proposition 65 recommends lead exposure of <0.5 µg/day and a mandatory warning
label for consumer products that exceed this limit.  Lead consumption should be <15 µg/day to
maintain BLLs <10 µg/dL. 
UNCA conducted a study on the amount of lead that is transferred from keys to hands.  The 
three phases of the study analyzed (1) daily handling and daily testing of five brands of new 
keys containing 1.4%-1.9% lead over five days; (2) long-term handling and periodic testing of
new keys over four weeks; and (3) intensive handling of ten used keys over three days.  The 
study showed that handling chrome-plated keys did not expose users to high levels of lead
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based on the Proposition 65 level of >0.5 µg/day.  Handling non-plated brass keys over time
appeared to expose users to concentrations of lead that might be harmful. 
Other activities over the past 13 years that have focused on lead in keys are summarized as
follows. In its 1996 report on lead in vinyl mini-blinds, the U.S. Consumer Product Safety
Commission (CPSC) noted that 50% of lead on hands is transferred to the mouth.  However,
the amount of lead in the mouth if keys are placed directly in the mouth is unknown. The
California State Attorney General sued 13 manufacturers of brass keys in 1999. 
The San Diego Union Tribune published an article in October 1999 citing results from another 
key study. The study showed that lead from keys was deposited on fingers at amounts well 
above the safe level when keys were used as intended by being held for 15 seconds to open a
lock. The study further demonstrated that some keys left lead up to 80 times more than the 0.5 
µg/day limit.  The average lead level detected on hands was ~19 times above the “no significant
risk level.”
Product 2 is vinyl-coated cords that often contain lead.  Studies show that handling PVC cords 
leaves lead residue on hands. Many adults and teens handle cords on a daily basis from 
headphones, phone chargers, computers, hairdryers, coffee makers and cameras.  Most 
individuals are not aware that vinyl-coated cords contain lead and do not wash their hands after 
handling these items.  However, cloth-covered cords and other products have been 
manufactured as alternatives to vinyl-coated cords. 
UNCA conducted an electric cord study to analyze routine handling of 40 phone and electric 
cords; determine initial and subsequent lead exposure on hands, and calculate daily exposure
from routine handling. The study showed that most PVC cords, even from a single handling,
exposed handlers to significant and sometimes relatively large quantities of lead.  Based on
results of the study, UNCA advised manufacturers to greatly reduce or discontinue the use of 
lead as stablizers of PVC. 
UNCA conducted a PVC products study with seven vinyl children’s products to analyze the rate 
of dust accumulation with induced degradation and determine whether lead dust levels >0.5
µg/day or cadmium dust levels >0.05 µg/day were produced.  Children’s products included in 
the study were raincoats, rain hats, backpacks, play tent poles and tote bags.  The study 
showed that all seven products had lead exposures levels >0.5 µg/day and all products tested
for cadmium were >0.05 µg/day. The study validated the concern that vinyl products might
produce toxic lead and cadmium dust levels.  All products tested in the study were found to be 
potential sources of lead or cadmium contamination for children. 
Product 3 is Mexican pottery that poses a risk to potters and families in Mexico and consumers 
in other locations who purchase these products.  Labels in both English and Spanish that are
misleading and confusing to consumers are one of the most significant concerns with Mexican
pottery. For example, one manufacturer advertises all of its clay products in Spanish as “safe
for preparing and storing food,” but the English translation means that the products are “food
contamination-free and dishwashable.”  In addition to misleading and confusing labels, Mexican 
pottery often has stickers or no permanent labels, no labels at all or labels in English only. 
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UNCA performed tests on several different types of Mexican pottery to determine the amount of 
lead leached from these products.  The “lead-free” label on one product passed the Food and
Drug Administration (FDA) leach limit of 1 ppm, but failed the Proposition 65 leach limit of 0.1 
ppm. Another product with no label failed both the FDA leach limit of 0.5 ppm and the 
Proposition 65 leach limit of 0.1 ppm. 
Ms. Block reported that she discovered several myths associated with Mexican pottery during
her recent site visit to Mexico. “Leaching diminishes to virtually no lead levels over time.”  “Lead
in pottery can be cured with garlic and boiling water.”  “Lead has never affected relatives who 
have used Mexican pottery for generations.”  “Lead will burn off and disappear if Mexican 
pottery is heated to over 1,250 degrees.”  “Lead is safer from aluminum.” 
UNCA has made a number of recommendations for Mexican pottery based on the flawed labels, 
leach test results and longstanding myths.  The sale of unsafe items should be discontinued and 
warnings about these products should be posted.  Labeling requirements should be enforced 
and improved with clearer wording, labels in both English and Spanish, and permanent labels 
rather than stickers.
Collaborations should be established with Barro Sin Plomo in Mexico because this group is 
attempting to train local potters in producing lead-free pottery.  Stronger efforts should be made 
in identifying sources of truly lead-free pottery in Mexico.  UNCA should initiate a pottery 
cooperative with potters from Mexico who now live in Asheville, North Carolina and are selling
pottery in local communities.
Product 4 is carpet. The ASTM International Sports Equipment and Facilities Committee
released a new standard for lead content in artificial turf fibers, but the standard does not cover
carpet.  Ms. Block tested tan carpet over concrete floors in the living room, hallway and
bedroom of a home and found that lead levels ranging from 1.62-2.38 mg/cm2 exceeded the
lead-based paint limit of >1 mg/cm2.  Tests of the carpet mesh in the home also exceeded the
lead-based paint limit.  Tests of dark brown and maroon carpet in another home showed non-
detectable lead levels, but lead levels in the tan carpet still remained high at 1,380 ppm. 
However, none of these tests provided conclusive evidence of actual exposure to lead from 
carpet.
Product 5 is other household items with lead levels ranging from 1,130-17,800 ppm and
children’s toys with lead levels ranging from 2.2-7.7 mg/cm2.  These items exceeded the lead-
based paint limit of >1 mg/cm2. The items that were tested included a drinking glass, brass bell, 
jewelry and vinyl boots.  CPSC informed UNCA that some of the toys are “antiques” and are not 
regulated as children’s items.  The manufacture and sale of lead-containing children’s toys and 
household items will serve as a significant barrier to achieving the goal of BLLs <2 µg/dL in all 
children.
Ms. Block noted that the studies she presented on keys and vinyl-coated cords were released
as technical reports.  She offered to provide these studies to ACCLPP for review.  She also 
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pointed out that UNCA’s “Where Lead Hides” resource document was distributed to ACCLPP 
for review. 
Mr. Perry Gottesfeld is the Executive Director of Occupational Knowledge International (OTI). 
He provided an international perspective on lead in consumer products.  OTI conducts the 
majority of its activities in developing countries to build capacity in environmental health issues.
As part of its mission, OTI is continuing to focus on the global lead poisoning epidemic.
The World Health Organization (WHO) estimates that 120 million persons are overexposed to
lead and 99% of the most serious cases are in the developing world.  Lead is commonly used in
thousands of products, but lead batteries account for 80% of lead globally.  Although the global 
lead poisoning epidemic occurs in every country in the world and impacts three times more
persons than HIV/AIDS, this issue attracts minimal attention internationally.  The WHO 2002 
World Health Report ranked lead exposure as number 16 of the top 20 risk factors for the global 
distribution of burden of disease.  However, lead exposure would be ranked as a top 10 
contributor to the global burden of disease if all risk factors for nutrition were combined. 
Developing countries are more susceptible to lead poisoning due to more opportunities for
exposure, the continued sale of lead-containing consumer products and paints, and the
increase of lead absorption as a result of poor nutrition.  Developing countries also have no
health screening programs; a higher proportion of lead; poor infrastructure and weak capacity 
for battery collection and recycling in modern or environmentally-efficient facilities; and a growth 
in the lead battery market.  Lead batteries account for the vast majority of exposure, but cable 
sheathing, rolled and extruded products, shots and ammunition, alloys, pigments, other
compounds and other miscellaneous items play a significant role in lead poisoning in developing
countries as well. 
The current practice in developing countries of welding battery plates together by melting lead
with an open flame demonstrates no improvements in battery manufacturing since the 1914
Hamilton study on lead poisoning in the manufacture of storage batteries.  Even in the most 
modern plants in developing countries, BLLs among workers exceed 50 µg/dL on average and
also are extremely high among children who live in communities near battery manufacturing
plants.
In an effort to address these problems, OTI introduced the “Better Environmental Sustainability 
Targets” (BEST) Certification and Eco-Label Program to reward lead battery companies that 
meet specific emission targets and agree to accept used batteries for proper recycling.
Companies that demonstrate compliance with the standard through annual audits can apply for 
the BEST Eco-Label for placement on their products.  In cooperation with industry, OTI
developed BEST as a minimum standard and launched the program in India in 2008.
Products other than lead batteries also contribute to the global lead poisoning epidemic.  Mobile 
and fixed-line industries have rapidly grown 20%-30% each year throughout the world due to
the increased use of mobile phones and fixed lines in developing countries.  The battery
company sector has greatly increased over the past ten years to meet the demand for the
emerging mobile and fixed-line markets in these areas of the world. 
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Philanthropists and computer companies developed marketing plans to close the “digital divide” 
by using lead batteries to power the next billion computers in the developing world by 2015.
OTI and the University of Tennessee recently conducted a life-cycle assessment that
conservatively estimated lead emissions from batteries of the billion computers would exceed 
~1.3 million tons of lead for computers sold by 2015. 
In addition to lead batteries, other automobile components that contain lead are being sold in 
the developing world, including wheel weights, alloying agents, coatings, electronic applications,
vibration dampers, automobile lighting, fuel hoses, PVC stabilizers, fuel tanks and brake linings.
The 2005 Clark, et al. study, 2007 Adebamowo, et al. study, and 2007 Mathee, et al. study all 
reported significant lead levels in new residential paint in China, India, Malaysia, Nigeria, 
Singapore and South Africa. Lead levels found in these studies ranged from 9%-100% over 
600 ppm and 0%-83% over 5,000 ppm.  The 2008 Lin, et al. study and 2008 Gottesfeld study in
China and India also showed significant lead levels in new residential paint ranging from 38%­
50% over 600 ppm and 24%-28% over 5,000 ppm.
Findings from the five studies conducted in 2005-2008 raised the question of whether an
international ban on lead in paint could be achieved.  Supporters of this initiative acknowledged
that the International Labour Organization of the League of Nation called for an international ban
on white lead in paint 88 years ago, but the ban was never formally ratified.  To renew this 
effort, Toxics Link called for a ban in 2008 that was backed by Nigeria, Germany, the United
States and other countries. The Strategic Approach to International Chemicals Management 
(SAICM) also approved the call to eliminate lead in paint and form an international partnership.
During the joint United Nations (UN)/SAICM conference that was held in May 2009, a formal
resolution was passed to establish a partnership on the global phase-out of lead in paint by 
conducting five major projects:  (1) raise awareness of toxicity to human health, the environment 
and alternatives; (2) provide guidance and assistance to identify potential lead exposure; (3) 
assist industry, including manufacturers, wholesalers and retailers; (4) establish prevention 
programs to reduce exposure; and (5) promote national regulatory frameworks. EPA also
played an instrumental role in passing the resolution on the global phase-out of lead in paint at
the international level.  ACCLPP and the paint industry submitted letters in support of the 
resolution as well.
Mr. Gottesfeld highlighted practices in two countries that account for the largest proportion of
lead-poisoned persons.  A recent study showed that despite the ban on lead in gasoline, 35% of
children in Southern India still have BLLs >10 µg/dL.  Vehicle production has rapidly grown in
India and has doubled in the past five years to 35%-40% lead consumption.  The two-wheeler 
segment has had the highest growth rate of >32%.  Backup power accounts for 35% of lead
consumption and continues to grow at 12% per year.  The per capita paint consumption in India
is only 1/20th of the use in the United States. India has no regulations on lead paint levels. 
The 2009 He, et al. study showed that despite the ban on lead in gasoline, 23.9% of children in 
China still have BLLs >10 µg/dL.  Lead production in China has rapidly grown and now accounts 
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for 40% of global lead production.  Battery sales as a result of increased demand for electric 
bicycles are expected to rapidly grow to 35.6% by 2012. 
The 2008 Frost and Sullivan/Liber Research study showed that revenues from the sale of 
electric bicycles have been doubling in China every two years since 2003.  Batteries in the
bicycles are the same size as those in automobiles, but only last for ~12 months.  Mass lead 
poisoning incidents have been documented in a number of provinces throughout China over the
past five years related to smelters and lead battery manufacturing facilities.  The per capita paint
consumption in China is only 1/10th of the use in the United States. 
OTI will conduct and participate in several projects in the future to decrease lead poisoning in
China. Collaborations will be formed with local partners to provide outreach and education on
lead poisoning prevention in China.  The California Department of Public Health Environmental
Health Program and the China CDC in the Shanghai and Guangzhou Provinces will convene a
joint conference in April 2010 to publicize the lead poisoning epidemic in China. 
In coordination with the Vehicle Emissions Control Center and the China Automotive
Technology and Research Center, outreach, education and training will be provided to lead 
battery companies and vehicle manufacturers to facilitate enforcement of pollution controls.  A 
voluntary environmental certification program will be launched for low-level lead paint. 
Dr. Kosnett devoted the remainder of the presentation to LCPWG’s draft charge that was 
distributed to ACCLPP for review, discussion and formal approval.  [Editor’s Note: Due to 
ACCLPP’s upcoming vote on this issue, the draft charge reflects no editorial changes and is 
captured below as read verbatim into the record by Dr. Kosnett.] 
1. “Building upon the formal liaisons that now exist between the CDC Advisory Committee
on Childhood Lead Poisoning Prevention and other federal agencies such as the
Consumer Product Safety Commission, the Food and Drug Administration, and the
National Institute for Occupational Safety and Health, the Work Group will recommend
and foster collaborative efforts to enhance awareness of the public health community 
and the public at large of methods to identify, reduce, and prevent childhood lead 
exposure from consumer products. These collaborative efforts might include, but not be 
limited to, development of web-based documents and educational resources,
participation in educational symposia and conferences, and consideration of domestic 
and international policy recommendations.  Particular attention might be devoted to the
development of a web page on the ACCLPP website that highlights the hazards posed
by lead in consumer products, and educates public and private sector lead poisoning 
prevention programs at the local and state level on steps that may be taken to facilitate
international awareness and cooperation on the elimination of lead hazards. 
2. Working with parties in the public and private sector, the Work Group should pursue 
efforts that support the convening of an international conference, possibly in China, that
addresses advances in the recognition, management, and prevention of lead poisoning 
in children and adults. Featuring invited contributions by health professionals, 
environmental scientists, public health officials, industrial hygienists, industry 
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representatives and other interested parties, the conference may have the following 
specific aims: 
 To foster an international consensus on the health risks posed by low and moderate 
levels of lead exposure, especially as demonstrated by recent epidemiological and 
clinical research; and
 To identify and promote public health strategies to reduce lead poisoning in children 
and adults, including health surveillance in communities and workplaces, educational 
outreach, pediatric case management, improved public health laboratory 
infrastructure, and primary prevention 
 To identify innovative approaches that can reduce lead exposure through voluntary 
certification programs and the reduction of nonessential uses of lead.”
Dr. Kosnett emphasized that LCPWG’s proposal to convene a bilingual international conference 
in the spring of 2011 would be feasible if efforts were made at this time to identify potential 
funding sources from both public and private sectors in the United States and China.  He noted
that LCPWG’s activities would result in two tangible products:  (1) recommendations and 
publications from the international conference and (2) the development of a web page to serve
as a resource for international sources of lead poisoning.
Dr. Brenda Reyes is an ACCLPP member and Bureau Chief of the City of Houston Health and 
Human Services. She noted that Houston has been closely collaborating with manufacturers of
Mexican pottery and FDA to address the problems Ms. Block outlined in her presentation.  To 
advance LCPWG’s efforts related to Mexican pottery, she offered to provide Dr. Kosnett and 
Ms. Block with contact information at FDA and data Houston has collected in this area to date.
In terms of LCPWG’s draft charge, some ACCLPP members noted differences in typical
workgroup charges. For example, most workgroups are charged with reviewing the literature
and formulating recommendations on a specific issue, but LCPWG’s draft charge focuses more
on activities that will be conducted.
In response to the panel presentations, several ACCLPP members made comments and
suggestions for LCPWG to consider in its ongoing efforts.
 LCPWG and UNCA should collaborate in conducting additional research to determine
the bioavailability of lead exposure from keys. 
 CDC should explore the possibility of inviting major trading partners outside of the United 
States to serve as liaison members on ACCLPP.  For example, health professionals and 
other groups in China, India and Mexico are extremely knowledgeable of the lead
poisoning epidemic and are attempting to address the same problems globally. 
 To forge stronger alliances in addressing lead in consumer products both domestically 
and internationally, LCPWG should link to ongoing and future efforts (i.e., the joint 
UN/SAICM initiative to establish an international partnership on the global phase-out of
lead in paint and the upcoming joint conference by the California Department of Public 
Health and China CDC).  
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 LCPWG should engage native-speaking researchers who received training on lead
poisoning in China, but now reside and are practicing in the United States. 
 LCPWG should identify and prioritize the top consumer products and focus its efforts on
those that pose the greatest risk for lead exposure. 
Dr. Brown made several remarks in follow-up to ACCLPP’s discussion.  The Federal Trade
Commission (FTC) has expressed a strong interest in pursuing cases of Mexican pottery with
ineffective or inaccurate labeling or those involving fraud.  She confirmed that she would provide
Ms. Block with contact information for FTC officials during the meeting. 
In response to the suggestion to invite major trading partners outside of the United States to
serve as liaison members on ACCLPP, Dr. Brown clarified that CDC’s Congressional line item 
and ACCLPP’s charter are limited to domestic lead poisoning prevention activities.  However,
she was extremely supportive of the proposal and made a commitment to explore mechanisms 
for persons representing international organizations to serve on ACCLPP as liaisons.
As potential international liaison members, Dr. Brown suggested representatives from China
CDC, the United Nations Environment Programme, or the new international partnership on the 
global phase-out of lead in paint. In the interim, she announced that the U.S. Department of 
State would be invited to join ACCLPP beginning with the next meeting  
Dr. Brown concluded the discussion by asking the ACCLPP members to review LCPWG’s draft
charge overnight for final deliberations and a formal vote during the business session on the
following day.
Overview of the Saliva Lead Testing Study
Dr. Gardner presented preliminary data from a study the Emory University School of Medicine
and its colleagues conducted to determine the accuracy of oral fluid lead testing.  The incidence
of lead poisoning has decreased in the United States, but ~250,000 new cases occurred in 
2008. Lead poisoned children are at higher risk for having neurodevelopmetnal deficits and
various behavior problems. Current screening practices are complicated by the need to obtain
blood from young children. Oral fluid can be used in vitro to appropriately measure lead in a
laboratory setting, but this matrix has not yet been tested in a clinical setting with a large 
number of children.
The study methods included the collection of oral fluid samples from 500 children 6 months to 5
years of age in a hospital-based primary care clinic.  All children who already had venous BLLs
drawn for routine screening purposes were eligible for the study.  BLLs were measured using a 
standard methodology at a laboratory certified by Clinical Laboratory Improvement Amendments
(CLIA).
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Oral fluid levels were measured using inductively coupled plasma-mass spectrometry (ICP-MS).
Oral fluid samples were collected from 50 children twice to validate internal controls, but were 
only counted once. Pearson correlations, scatter plot and linear regression were used to
analyze data. The mean absolute difference between the sample groups was determined to
test the hypothesis that group means were equal. 
Results of the study are summarized as follows.  All 500 eligible patients agreed to participate in
the study. Of the entire sample, 474 patients had both blood and oral fluid samples available for 
analysis and the remaining 26 patients had no blood samples available.  Of 474 patients who 
had both blood and oral fluid samples available, 455 had BLLs <5 µg/dL and all of these 
patients had corresponding oral fluid lead levels <5 µg/dL.  The remaining 19 patients had BLLs
>5 µg/dL and all of these patients had corresponding oral fluid levels >5 µg/dL. 
The authors reached several conclusions based on the study results.  Oral fluid appeared to be
a reliable medium to use when screening children for lead exposure.  Oral fluid lead levels >5 
µg/dL should be confirmed by a venous blood sample.  The sample size of 19 children who had
oral fluid levels >5 µg/dL was inadequate to draw conclusions on oral fluid reliability at these
levels. As a result, further studies are being conducted.  The convenience of lead screening
with oral fluid measurements should improve the success of screening by reducing parental 
refusal and eliminating the inability to obtain adequate samples.  This method of screening will 
allow very large groups of children to be screened more quickly and easily than conventional 
methods. 
Dr. Anil Mangla is the Chief Lead Epidemiologist for the Georgia Department of Community
Health and one of the authors of the saliva lead testing study.  He joined the ACCLPP meeting
by conference call to provide additional details on the study.  He explained that data from the 
study were submitted to the University of Georgia Department of Biostatistics for independent 
validation, analysis and comparison of the results. At the completion of the independent review, 
the study would be submitted for publication in a peer-reviewed journal over the next month.
The complete data analysis of the study also would be presented at the 2009 National Public 
Health Environmental Conference. 
In response to Mr. Gottesfeld’s question, Dr. Mangla emphasized that the methods of the saliva 
lead testing study have no connection to the LeadConfirm ProfessionalTM saliva lead screening 
kit. He contacted the company and requested predictive values, cutoff points, false-positive/
false-negative rates, sensitivity/specificity rates and other supporting data for the test.  Dr.
Mangla has received no response to his request from the company to date. 
In response to Dr. Cory-Slechta’s question, Dr. Mangla explained that the manufacturer plans to 
market the saliva lead test for ~$35-$40.  However, he acknowledged the need to reduce this 
cost, particularly if the test is first piloted in the high-risk Medicaid population. 
Dr. Patrick Parsons, of the New York State Department of Health, is chair of ACCLPP’s
Laboratory Methods Workgroup on Lead Poisoning Prevention.  His position was that feedback
on the saliva lead testing study would be premature at this point without ACCLPP’s review and 
examination of the data from both clinical and analytical perspectives.  For example, he noted
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enormous uncertainty associated with the density and volume of saliva collected on the sample
preparation slides.
Dr. Parsons also expressed concern about the extraordinary capability required to measure low 
concentrations in saliva lead while avoiding contamination.  The peer-reviewed literature 
documents that saliva lead closely follows plasma lead and would only represent a small 
fraction of blood lead concentrations.  In addition to contamination controls for low saliva lead
levels, he emphasized that questions also need to be answered regarding traceability of the
measurements and reference materials for saliva lead need to be collected. 
Similar to Dr. Mangla, Dr. Parsons announced that the New York State Department of Health 
also contacted the manufacturer of the LeadConfirm ProfessionalTM saliva lead screening kit
and requested the validation package for independent verification of the validity of the test.
Because the company refused to submit the validation package due to the proprietary nature of
the data, the LeadConfirm ProfessionalTM saliva lead screening kit cannot be marketed in New 
York without open and transparent review of the data. 
Dr. Parsons reiterated the need for ACCLPP to determine the role of the saliva lead testing
study in a public health context only after the independent review and validation of the data
have been completed.  To assist ACCLPP in this effort, he conveyed that the Laboratory 
Methods Workgroup would propose conducting research on saliva and other alternative
matrices for assessing exposure to lead. 
Dr. Robert Jones, of CDC, also joined the ACCLPP meeting by conference call.  He encouraged 
the authors of the saliva lead testing study to review the National Committee for Clinical 
Laboratory Standards.  He pointed out that guidelines 9-A specifically provide guidance on
comparing different laboratory methods and might serve as a useful resource in validating the 
conversion from oral fluid lead levels to BLLs. 
ACCLPP shared many of the concerns Dr. Parsons raised regarding the saliva lead testing 
study. Several members emphasized that obtaining corresponding lead levels in blood and oral 
fluid in the same patient would be impossible.  Some members also were concerned about the 
inconsistency and discrepancy between these findings and rigorous laboratory studies with well-
controlled study designs that have been recently documented in the published literature. 
ACCLPP agreed with Dr. Parsons on the need to reserve its input on the saliva lead testing
study until after the supporting data were submitted and thoroughly reviewed.  In the interim,
however, the members made a suggestion for the authors to consider before presenting the 
study at the 2009 National Environmental Public Health Conference the following week.
ACCLPP advised the authors to thoroughly review and revise the conclusions.  For example, 
the authors concluded that oral fluid appeared to be a reliable medium to use when screening
children for lead exposure.  However, this conclusion conflicts with the recommendation to
confirm oral fluid lead levels >5 µg/dL with a venous blood sample. 
Dr. Rhoads concluded the discussion by describing ACCLPP’s next steps on the saliva lead 
testing study.  The Laboratory Methods Workgroup would be charged with conducting a detailed
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analysis of the study. The authors would facilitate this effort by providing the workgroup with
raw results from the ICP-MS, the algorithm that was used to convert oral fluid lead levels to 
BLLs, and data from all 474 patients who had both blood and oral fluid samples available. 
Public Comment Session 
Ms. Jane Malone is the ACCLPP liaison to the Alliance for Healthy Homes (AFHH). She
announced that the International Code Council would hold a hearing on November 4, 2009 to
update and approve model codes for adoption by states and jurisdictions.  ICC would consider 
two major issues during the hearing.  First, the International Property Maintenance Code would 
be revised to require LSWP for the repair of deteriorated paint in pre-1978 properties.  Second,
EPA’s new Renovation Rule requirements would serve as the standard of practice for all 
repairs, alterations and renovations to existing properties and would be enforced by building 
officials throughout the country. 
Mr. Perry Gottesfeld, of Occupational Knowledge International, was pleased that the saliva
lead testing study had no relationship to the LeadConfirm ProfessionalTM saliva lead screening 
kit. The company is marketing the test as an “FDA-approved collection kit that is reliable as
blood laboratory tests.”  Mr. Gottesfeld found this advertisement to be deceptive because only
the saliva collection method, not the LeadConfirm ProfessionalTM kit itself, is FDA-approved. 
In response to Mr. Gottesfeld’s comments, Ms. Kite expressed an interest in ACCLPP revisiting
the deceptive advertising practices of the LeadConfirm ProfessionalTM saliva lead screening kit
at a future meeting. She raised the possibility of ACCLPP educating parents who have
purchased the test and also taking formal actions with FDA to force the company to clarify its 
website. 
Mr. Craig Boreiko is a Research Administrator at the International Lead Zinc Research
Organization (ILZRO). He explained that ILZRO and the Basel Secretariat of the United Nations 
Environment Programme have been collaborating over the past six years to develop
cooperative regional strategies for the end-of-life disposition of batteries in developing countries. 
The most significant problem in this initiative is that many countries in the developing world do 
not have sufficient throughput or volume of materials to maintain an economically viable
recycling infrastructure.  Moreover, efforts to develop cooperative regional strategies have been 
blocked by current international regulations on the transport of hazardous materials.
ILZRO and the Basel Secretariat have piloted battery recycling programs in the Caribbean and
Latin America and hope to expand the pilot to Africa and Southeast Asia based on UN funding. 
A meeting was held with representatives of Chinese industry in September 2009 and initial 
memoranda of understanding were established to explore various avenues for the transfer of
technology and expertise. Despite ongoing cultural and political barriers, China has recognized
its severe lead poisoning problem and is anxious to achieve a formal resolution.  Mr. Boreiko 
was pleased to announce that a number of other organizations have joined the outreach efforts
in China and similar progress in India is expected in the near future. 
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Dr. Brown pointed out that a table was distributed outlining the status of comments submitted by 
ACCLPP on the July 8, 2009 version of the draft lead and pregnancy paper.  She asked the 
members to review the table overnight in preparation of ACCLPP’s voice vote on the paper that
would be taken on the following day. 
With no further discussion or business brought before ACCLPP, Dr. Rhoads recessed the
meeting at 4:35 p.m. on October 21, 2009. 
Update by the Laboratory Methods Workgroup on Lead Poisoning Prevention 
Dr. Rhoads reconvened the ACCLPP meeting at 9:04 a.m. on October 22, 2009 and yielded the
floor to the first presenter. 
Dr. Patrick Parsons is the chair of the Laboratory Methods Workgroup (LMWG).  He covered
the following areas in his update.  LMWG’s nine members represent ACCLPP, CDC, state 
health departments, academic universities and a commercial laboratory.  LMWG is requesting
ACCLPP’s guidance at this time on whether its existing membership should be confirmed and/or 
expanded. LMWG has already identified two potential new members:  Dr. Donald Simmons as
a liaison to the Association of Public Health Laboratories and Dr. Michael Kosnett as another 
ACCLPP member who also would provide expertise to LMWG based on his position as a 
medical toxicologist at the University of Colorado Health Sciences Center. 
LMWG convened two meetings in March and June 2007 and used its last meeting in July 2007
to draft and circulate a report.  However, no progress was made on these initial efforts because
ACCLPP did not give LMWG a formal charge and CDC had no budget to support additional 
meetings. LMWG plans to hold meetings in the future pending a formal charge from ACCLPP
and support from CDC.
ACCLPP previously approved the establishment of LMWG due to the need to more closely 
focus on proficiency testing limits for blood lead and achieve “consensus” on tighter
requirements at low BLLs. The position of the clinical laboratory community is that the limit of 
+4 µg/dL established by CLIA more than ten years ago is overly generous.  The clinical
laboratory community also believes that the limit of +4 µg/dL is not consistent with current
technology and a limit of +3 µg/dL would be feasible at this time.
During its initial meetings, LMWG agreed that improvements in laboratory accuracy to achieve
the limit of +3 µg/dL would not result in a measurable impact on the number of laboratories 
failing proficiency testing.  LMWG noted that a limit of +2 µg/dL might be possible after a few 
years. LMWG recognized the need for ACCLPP to send a formal letter or statement to CMS 
recommending a change in the regulations to permit flexibility for proficiency testing providers to
establish limits that are consistent with program and medical needs and current laboratory 
capabilities.
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ACCLPP also approved the establishment of LMWG due to the need to analyze and provide
guidance on proficiency testing issues regarding the LeadCare instrument.  This point-of-care
blood lead testing device is being used more frequently across the country, but the instrument is 
being implemented with minimal training and oversight.  In an effort to improve this area, New 
York State developed and widely shared practice standards with regulated full-service 
laboratories, laboratories in physicians’ offices and limited testing laboratories.
CLIA classified the original non-automated hand-held LeadCare device as “moderately
complex” and “waived” the newer non-automated device.  The difference between the two
devices emphasized a strong need for standards.  In response to this issue, New York State
developed the following practice standards for the LeadCare instrument.  Manufacturer’s 
instructions should be followed.  Only fresh whole blood should be analyzed. 
Aged blood older than 24 hours, refrigerated blood and frozen samples should not be analyzed.
Samples from patients with BLLs >8 µg/dL should be referred to a certified laboratory for
analysis using a reference method.  Test results should be used for screening purposes only. 
All blood lead test results should be reported to the health department.  Staff should be trained
to ensure competency.  LeadCare results should be maintained for record keeping.
Dr. Parsons proposed several new activities LMWG could conduct at the direction of ACCLPP.
For activity 1, LMWG could undertake a systematic review of the literature on saliva lead, 
assess new testing approaches that might be promoted by commercial companies, and
formulate recommendations in this area. 
For activity 2, LMWG could validate other new clinical tests based on robust peer-reviewed
publications in appropriate journals (i.e., Clinical Chemistry or Clinica Chemica Acta) or based
on regulatory oversight and approval as a result of federal or state requirements.  LMWG could
use New York State’s validation requirements for clinical tests as a model in this effort.  New 
York State requires the rationale and utility of each clinical test to be justified with a strong basis 
or comparison to a reference method.  New York State must be provided with a validation
package that addresses pre-analytical, analytical and post-analytical issues. 
The performance of the clinical test must be demonstrated.  At the clinical level, data must be
provided on the diagnostic specificity and sensitivity of the test as well as its false-positive and
false-negative rates. At the analytical level, data must be provided on the detection limit, 
measurement precision, repeatability, reproducibility, accuracy and traceability of the test.  The
interpretation, reference interval and reporting units of test results must be submitted.  New York 
State’s validation requirements for clinical tests can be viewed on the website of the New York
State Department of Health Wadsworth Center at www.wadsworth.org. 
For activity 3, LMWG could analyze other biomarkers of lead exposure in packed red cells, hair,
nails, breast milk or sweat.  However, the challenges in analyzing these biomarkers include 
limited capacity to accurately convert different units and ranges to whole blood; the absence of 
proficiency testing requirements, certified reference materials and quality assurance/quality 
control measures; and contamination issues.
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For activity 4, LMWG could perform environmental analyses to address the disconnect between
acceptable lead limits established by multiple agencies.  These differences include lead levels in 
drinking water, soil in play areas and dust established by EPA; various lead levels in food 
established by FDA; the residential wall paint lead level established by HUD; and various lead 
levels in consumer products established by CPSC.  Moreover, many of the existing lead level 
limits established by federal agencies that are harmful to children are based on old data. 
LMWG’s environmental analyses could validate “promises” by manufacturers of the ability of
their new devices to better detect lead in paint, toys and other consumer products in the field.
LMWG recognizes the need to educate users on the limitations of these new technologies.
Because federal regulations are now requiring lead measurements at lower levels, LMWG could
conduct research to determine whether current analytical methods are adequate for testing
samples of paint and other consumer products for lead content. 
LMWG’s environmental analyses also could include regulatory oversight; standards developed
by the National Environmental Laboratory Accreditation Conference and the NELAC Institute; 
and new CPSC regulations requiring International Organization for Standardization certification 
of laboratories that test consumer products.
The Consumer Product Safety Improvement Act of 2008 established new limits on lead 
concentrations in paint of 90 ppm following the 2007 recall of millions of toys produced in China 
that were contaminated with lead >600 ppm.  This legislation also decreased the total lead
content to 300 ppm beginning in August 2009 and will further reduce the total lead content to
100 ppm beginning in August 2011.  Dr. Parsons showed photographs and briefly described the 
new devices. 
Mr. Jeffrey Jarrett, of the Division of Laboratory Science at CDC, presented analytical 
considerations and other issues related to saliva lead measurements based on a recent review 
of the literature.  The interest in saliva testing for multiple applications has greatly increased
over time. Since 1982, >2,500 articles have been published in the peer-reviewed literature 
reporting the use of saliva as a diagnostic fluid.  These papers have covered a wide range of 
biomonitoring issues, including drug monitoring, hormone testing, validation of self-reported
frequency of smoking, estimates of dietary intakes, genetic testing, and detection of various 
systemic maladies.  The number of publications related to saliva lead measurements has 
increased from 0 in 1981 to ~50 at the present time.
Saliva is a complex mixture before and after entering the mouth and includes water, multiple
glycoproteins, blood cells, microorganisms, epithelial cells, food debris and upper-airway 
secretions. The production of saliva varies throughout the day and depends on the nature,
duration and intensity of the stimulus.  Low pH levels, high-frequency chewing and high bite
force increase output and must be taken into consideration when collecting saliva samples.
Individuals produce 0.5-1.5 liters of saliva per day.  The submandibular glands produce 50%­
75% of saliva; the parotid gland produces 20%-50% of saliva; and the sublingual and other 
glands produce 5%-10% of saliva.
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Mr. Jarrett summarized key findings that have been documented in the literature regarding
saliva lead measurements.  The collection of saliva lead samples is non-invasive and less 
traumatic for patients. A sufficient volume of 1-5 mL of saliva is typically easy to collect in five 
minutes. Saliva lead testing costs less than traditional testing because no specialized training is 
necessary.  Other benefits of saliva lead testing that have been reported include no risk to 
patients of infection, anemia or thrombosis and a safer method than blood collection for health 
professionals. 
Saliva lead testing reflects real-time levels of biomarkers of lead because lead in saliva is the
direct excretion of the diffusible lead fraction in plasma that is not bound to proteins. Some 
researchers have suggested that this fraction is highly associated with the toxic effects of lead.
The question has been raised in the literature about whether saliva would be considered as
medical waste and could benefit from disposal costs.
Issues or limitations that should be considered in sampling saliva lead measurements include
variations of saliva composition throughout the day.  These differences are influenced by
circadian rhythms, medications, stimulation methods, gender, age, gland size, psychological 
effects, health and nutrition. The susceptibility of contamination is amplified by low saliva lead 
concentrations. 
Environmental contamination can be minimized with a clean and controlled environment to
collect saliva samples and rigorous methods to pre-screen all collection supplies.  Intra-oral 
contamination can be minimized with fasting and mouth rinse with water prior to saliva collection 
to reduce the impact of lead in metallic dental restorations and also to remove food debris, 
blood in saliva and smoking residue. 
Issues or limitations that should be considered in analyzing saliva lead measurements include
extremely low levels that limit the range of suitable analytical techniques. To date, CLIA has not
approved any standard or certified reference materials for quality assurance of saliva lead
measurements.  To date, CLIA has not approved an external quality assurance or proficiency 
testing program for saliva lead measurements. 
Issues or limitations that should be considered in utilizing saliva lead measurements include the
absence of reliable published correlations between lead levels in saliva and those in blood or 
plasma. Reliable reference saliva lead values for human populations have not been produced 
to date. Both of these limitations increase the difficulty of interpreting the health significance of
observed saliva lead concentrations.
Mr. Jarrett cited excerpts from three review articles on saliva lead measurements that are
documented in the literature.  The 2005 Barbosa, et al. review article concluded:  “In the
absence of consistent and dependable saliva lead measurements, it is not generally accepted
as a reliable biomarker of lead exposure.  Uncontrolled variation in salivary flow rates, lack of
standard or certified reference materials and absence of reliable reference values for human
populations are major factors that limit the utility of saliva lead measurements.”
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The 2007 Koh review article concluded:  “In practice, the use of saliva lead in biomonitoring is 
probably limtied to situations of higher levels of lead exposure and blood contamination of saliva
is a potential problem. Measurement of lower levels of lead in the saliva can also pose 
technical challenges.”  The 2009 Esteban review concluded:  “The disadvantage of saliva is 
related to its flow, which is influenced by many factors.  Saliva flow does not influence all 
substance concentrations to the same degree, so it can still be a useful matrix for non-flow­
dependent chemicals.”
Mr. Jarrett described two commercial saliva lead test kits that are currently on the market, but 
he clarified that the mention of company or product names does not constitute endorsement by
HHS, CDC or NCEH.  In 2004, American Medical Saliva Testing, Inc. stated:  “Using Oral Fluid
ELAN DRCc ICP Mass Spectrometer testing, one obtains similar information on the status of a 
person as one can obtain from whole blood.”  This test was marketed for whole saliva collection
with a sample collection time <2.5 minutes.  The manufacturer provided information for users to 
submit samples to an EPA-approved and CLIA-certified laboratory for analysis by ICP-MS with
“capabilities as low as 30 ppt.” 
The LeadConfirm ProfessionalTM saliva lead screening kit can be purchased from Confirm 
Biosciences at www.amazon.com. The test is marketed for “convenient saliva collection at 
home” with the capability of producing an “affordable and comprehensive lead report from a
CLIA-accredited laboratory” that uses state-of-the-art liquid high-performance chromatography 
with mass spectrometry.  The manufacturer claims the test is 99.9% accurate, FDA-approved
and as reliable as blood laboratory tests.  The manufacturer claims 100% correlation between 
lead levels found in saliva and blood,
The manufacturer further claims that “analyzing saliva is an effective means to establish body
lead, especially if this test is viewed as a screening method with the recommendation of a
physician involved in the event results exceed a certain level.”  The manufacturer also describes 
the ease in using the test by placing a sponge applicator in the mouth for saturation by saliva. 
Instructions are given on mailing the applicator to the laboratory and receiving full results of lead
levels in the body in two days. 
Dr. Parsons concluded the update by presenting LMWG’s proposed charge.  In general, he 
emphasized that ACCLPP should clearly define the scope of advice solicited from LMWG.  CDC 
also should provide administrative support to enable LMWG to meet and produce a document
that addresses laboratory methods issues.  In particular, Dr. Parsons proposed activities in five 
categories and requested ACCLPP’s guidance on prioritizing these issues.  He noted that
LMWG would use ACCLPP’s feedback to clearly define its next steps and future direction. 
1. Proficiency Testing Limits
 LMWG will address whether blood lead proficiency testing acceptability limits should 
be more stringent than the current CLIA 1988 standard of +4 µg/dL or +10%,
whichever is greater, and if so, what these limits should be.
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 LMWG will draft ACCLPP’s letter to the appropriate federal agency recommending 
that a change in the CLIA 1988 regulations be implemented to tighten the minimum 
acceptable proficiency limits for blood lead.
 2. Practice Standards for Point-of-Care Lead Testing
 LMWG will address the need for recommended standards of practice for those using 
point-of-care blood lead testing.
 3. Alternative Matrices for Assessing Exposure to Lead
 LMWG will investigate and report to ACCLPP the reliability and validity of measuring 
lead in saliva as an index of lead exposure.
 LMWG will investigate and report to ACCLPP the reliability and validity of measuring 
lead in proposed matrices, [i.e., saliva, sweat, hair, packed red cells or nails] as an
index of lead exposure. 
4. Environmental Lead Analytical Issues
 LMWG will investigate and report to ACCLPP the reliability of current technologies 
for assessing lead content of paint, plastics and other environmental samples, 
existing laboratory capacity and capabilities for handling samples.
 5. Reference Intervals for Adult Lead Exposure
 LMWG will investigate and report to ACCLPP approaches clinical laboratories should
take to report the reference interval for adult lead exposure.  Many laboratories now 
report BLLS <20 µg/dL and <30 µg/dL as “normal” for adults. 
To compliment LMWG’s proposed activities, Dr. Brown asked ACCLPP to consider writing a
guidance document for CLPPPs during a future meeting.  The document ideally would contain a 
list of questions for CLPPPs to ask vendors who sell new commercial lead screening kits for
saliva, nails, sweat or any other matrix.  ACCLPP’s guidance document to CLPPPs also would 
contain a set of appropriate responses from vendors. 
Mr. Jonathan Wilson is the ACCLPP liaison to the National Center for Healthy Housing (NCHH).
He announced that NCHH and AFHH recently sent a petition to EPA requesting a reduction in 
floor dust lead levels to 10 µg/sq. ft and window sill lead levels to 100 µg/sq. Dr. Brown 
confirmed that CDC would provide ACCLPP with information on this activity to ensure the
members had an opportunity to respond to EPA in a timely fashion.  
Ms. Jacqueline Mosby is ACCLPP’s ex-officio member for EPA.  She announced that EPA is in
the process of developing an accreditation program or registry for portable devices (i.e., XRF
and spot test kits) to test lead in paint, dust, soil and water.  She clarified that EPA will not use 
the accreditation program for products.  EPA expects to finalize the accreditation program some
time in FY2010.  Ms. Mosby anticipated being able to provide an update on this initiative during 
the last ACCLPP meeting in 2010.
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In response to a request by Dr. Kosnett, Ms. Mosby confirmed that EPA also would make a
presentation during the March 2010 ACCLPP meeting.  EPA is reviewing its lead hazard 
standards and recent data to determine whether a new metric should be used to evaluate 
screening and intervention values for lead in environmental media with BLLs <10 µg/dL.  Ms.
Mosby conveyed that EPA would welcome input from ACCLPP on appropriate changes to its 
current lead hazard standards. 
Ms. Dominique Williams attended the ACCLPP meeting on behalf of Dr. Kristina Hatlelid, 
ACCLPP’s ex-officio member for CPSC. She made a commitment to provide ACCLPP with an 
update on CPSC’s progress in utilizing XRF and other alternative methods to test consumer 
products for assessing lead exposure. 
ACCLPP made several comments and suggestions on LMWG’s proposed charge in response
to Dr. Parsons’ request for input and guidance.
 The current practice by many laboratories of reporting BLLS <20 µg/dL and <30 µg/dL
as “normal” for adults should not be considered as a part of LMWG’s charge.  
 LMWG’s charge should include a review of filter paper technology. 
 LMWG should develop a paper that describes alternative matrices for assessing
exposure to lead in general and includes a critical review of each matrix.  LMWG should
not develop an analytically detailed document on specific products because this activity
would fall beyond the scope of ACCLPP’s charter. 
 LMWG’s top three priority charges should be proficiency testing (#1), practice standards
for point-of-care lead testing (#2), and reference intervals for adult lead exposure (#5). 
 LMWG’s actions on proposed charge #3 (alternative matrices for assessing exposure to
lead) should be limited to immediately producing a cautionary statement.  For example, 
LMWG could clearly articulate the limitations of saliva lead testing and submit this 
information to CDC for immediate posting on the ACCLPP web page. 
 LMWG should add “efficacy” or “feasibility” after “reliability and validity” in the second
bullet under proposed charge #3. 
 LMWG’s proposed charge #4 (environmental lead analytical issues related to consumer 
products) should be prioritized because the identification of environmental pathways
plays a critical role in solving clinical problems related to lead.  If ACCLPP approves 
charge #4 as a priority, LMWG should explore the possibility of providing oversight to the
program developed by the Toy Industry Association.  If ACCLPP approves charge #4 as 
a priority, LMWG should ensure that all activities are conducted in close collaboration
and coordination with CPSC and EPA. 
 LMWG’s proposed charge #5 (reference intervals for adult lead exposure) should be
prioritized due to previous successes in this area at the state level.  For example,
Michigan recommended that its laboratories strengthen reference intervals for adult 
BLLs and all laboratories in the state were able to comply with this standard as of 2007.
Michigan’s accomplishment could be used as an opportunity for healthcare providers to
make an important change in lead poisoning prevention practices.
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A motion was properly placed on the floor and seconded by Drs. Sandel and Reyes,
respectively, for ACCLPP to formally charge LMWG with conducting the proposed activities in
all five categories as outlined by Dr. Parsons.
Dr. Rhoads made a friendly amendment to the motion to provide LMWG with more specificity
and direction on the charge based on ACCLPP’s discussion.  LMWG’s top four priorities would
be tighter proficiency testing limits (proposed charge #1); practice standards for point-of-care
testing (proposed charge #2); development of a statement on reference values for adult lead
exposure (proposed charge #5); and development of a statement on the use of saliva for
assessing exposure to lead (proposed charge #3).  LMWG would provide regular updates to
ACCLPP to obtain guidance on the feasibility of analyzing and making recommendations on 
other matrices in the future.  LMWG would coordinate its activities with ongoing efforts by CPSC 
and EPA.
Drs. Sandel and Reyes accepted Dr. Rhoads’ friendly amendment.  ACCLPP unanimously 
approved the motion as modified with no further discussion.
Final Update by the Lead and Pregnancy Workgroup (LPWG) 
Dr. Brown confirmed that in response to ACCLPP’s previous comments, changes related to
chelation during pregnancy were made in the text of the July 8, 2009 version of the draft lead
and pregnancy paper.  The same revisions would be made to Table 6 subsequent to the
meeting. 
Dr. Cory-Slechta expressed concern regarding Dr. Kosnett’s proposed change to add “certain”
before “cells” on page 11, line 22 of the paper. The original sentence was:  “Lead appears to be 
preferentially accumulated by cells in the brain, perhaps disrupting the blood brain barrier.”  Dr.
Brown proposed the following language to resolve this issue:  “The brain is the target organ for 
lead and lead in the brain may disrupt the blood brain barrier.”  Both Drs. Cory-Slechta and
Kosnett agreed with this language.
A motion was properly placed on the floor and seconded by Drs. Sandel and Cory-Slechta,
respectively, for ACCLPP to approve the lead and pregnancy paper with the change noted for 
the record. ACCLPP approved the motion with a majority vote, one abstention (Rhoads)
and no further discussion.
Ms. Nikki Walker, of LPPB, described CDC’s plans to rollout Guidelines for the Identification and 
Management of Lead Exposure in Pregnant and Lactating Women in the spring of 2010. 
Outreach and communication to providers would include newsletters, listservs, placement of the
lead and pregnancy logo in journals, and op-ed articles in journals of professional organizations.
The LPWG members made commitments to publish op-ed articles of the lead and pregnancy 
paper in the journals of their respective organizations, including the American Academy of
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Family Medicine, American College of Nurse Midwives, American Academy of Pediatrics, and
American College of Obstetricians and Gynecologists.
Outreach and communication to CLPPPs would include a webinar, newsletters and listservs to 
assist CLPPPs in answering questions from their constituents.  Other components of the 
communication rollout would include fact sheets to providers, public health professionals and
the general public; a web spotlight and podcast; and announcements on Facebook, Twitter, 
blogs and other social media.  The lead and pregnancy document also would be linked to the
websites of other CDC National Centers, particularly the pregnancy website of the National 
Center for Birth Defects and Developmental Disability. 
Dr. Jessica Leighton, an ACCLPP member and chair of LPWG, described issues in the lead and 
pregnancy paper that most likely would cause concern:  issues related to BLLs 5 µg/dL versus 
10 µg/dL; Occupational Safety and Health Administration recommendations; general screening
recommendations for pregnant or lactating women in high-risk communities; the calcium 
recommendation of 2,000 mg; and the calculation used to arrive at BLLs >40 µg/dL as a caution
for breastfeeding.
Ms. Walker added that CDC would develop and post a question/answer sheet on its website to 
specifically address the major issues Dr. Leighton described and other highly technical or
scientific questions CLPPPs or healthcare providers might have difficulty in answering.  The
web site also would provide a toll-free telephone number at 1-800-CDC-INFO for persons to 
obtain additional information. 
In terms of dissemination, Ms. Walker conveyed that CDC would develop and distribute all 
materials associated with the lead and pregnancy paper in both English and Spanish.  She
encouraged ACCLPP to provide her with additional suggestions on the rollout of the lead and
pregnancy paper at mwalker@cdc.gov. 
ACCLPP made several comments and suggestions for CDC to consider in the rollout and 
dissemination of the lead and pregnancy paper. 
 CDC should link the lead and pregnancy paper to the websites of the National Institutes 
of Health (i.e., the National Institute of Child Health and Human Development and the
National Institute of Environmental Health Sciences), other federal partners, the
Institution of Higher Education and advocacy groups. 
 CDC should provide CLPPPs with “sound bites” or other information to respond to 
questions and concerns regarding payment to conduct blood lead testing of pregnant
women.
 CDC’s rollout of the lead and pregnancy paper should be designed to deliver messages
to the most at-risk populations, such as pregnant women and women of child-bearing 
age who are renovating old homes. 
 CDC should link the lead and pregnancy document to the websites of occupational 
organizations, such as the American College of Occupational Environmental Medicine,
Adult Blood Lead Epidemiologic and Surveillance Program, Association of Occupational 
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and Environmental Clinics, and American College of Medical Toxicology.  CDC should 
submit op-ed articles to the journals of these organizations as well.  CDC should use Dr. 
Walter Alacon, ACCLPP’s ex-officio member for the National Institute for Occupational 
Safety and Health, as well as Drs. Kosnett and Rhoads as resources in outreaching to
the occupational community.  Dr. Kosnett offered to contact an organization in the United
Kingdom that will soon release a similar document on lead in pregnancy to explore the 
possibility of this group writing an editorial on ACCLPP’s paper. 
Dr. Brown made several remarks in response to ACCLPP’s comments and questions.  In terms 
of payment, blood lead testing of pregnant women should be considered a part of usual and 
customary care.  The position of CDC and experts in the field is that blood lead testing should 
not be viewed as a special test or exception to routine care of pregnant women.
With respect to early distribution of the document, Dr. Brown would determine the point at which
ACCLPP members could share a draft version of the lead and pregnancy paper with colleagues 
prior to publication. In the interim, however, ACCLPP members could reference the document 
as a draft that has been submitted to CDC for final approval and clearance. 
The participants applauded Drs. Leighton and Brown for their outstanding leadership over the
past few years and also commended the diligent efforts of Dr. Adrienne Ettinger, other LPWG 
members and CDC staff for their tremendous accomplishment of completing the lead and
pregnancy document. 
Update on CPSC Lead Poisoning Prevention Strategies 
Mr. Matt Howsare, Esq. is the Legal Counsel to the Chairman of CPSC.  He presented CPSC’s 
updated strategies and approach to address lead poisoning prevention.  Following the 2007
recall of lead-contaminated toys produced in China, the Consumer Product Safety Improvement 
Act of 2008 (CPSIA) was developed with stricter lead standards.  Since that time, CPSC’s
primary focus areas in lead poisoning prevention have been implementation and enforcement of 
the new CPSIA standards and education to domestic and foreign manufacturers and consumers
in complying with these laws. 
Mr. Howsare highlighted key components of CPSIA.  CPSIA reduced the lead in paint standard
for children’s toys and furniture from 600 ppm to 90 ppm.  CPSIA’s stricter standards on
leachable lead from children’s metal jewelry allowed CPSC to enforce a lead content standard 
of 300 ppm for a consumer product or any of its parts.  However, the lead content standard will 
be further reduced to 100 ppm beginning in August 2011 if CPSC determines the standard is 
technologically feasible.
The lead content standard is restricted to children’s products, but CPSC is currently developing 
a rule to clearly define “children’s products.”  The existing statute defines “children’s products”
as those primarily intended for children <12 years of age.  New CPSIA testing and certification 
requirements require third-party independent testing for compliance with standards, regulations 
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and bans enforced by CPSC, including the lead in paint and lead content standards.  These
requirements are expected to become effective in February 2010.  CPSC also enforces ASTM 
International Standard F963.  This mandatory toy safety standard is covered by CPSIA and
requires testing of lead and five other heavy metals in the surface coating of children’s toys. 
Mr. Howsare summarized CPSC’s five major compliance strategies.  One, CPSC monitors U.S.
ports to prevent dangerous products, including those containing excessive amounts of lead,
from entering the marketplace.  CPSC uses the XRF device to test products for lead at ports.
Dangerous products are destroyed at U.S. ports or sent to the CPSC laboratory for further 
testing and are not returned for sale in other countries under any circumstance.
Two, CPSC is continuing its retail surveillance with 100 field investigators who visit the 
marketplace, collect samples of products, and send samples to the CPSC laboratory for testing 
to confirm compliance. 
Three, CPSC is strengthening and expanding its partnerships with state attorney generals, 
poison control centers, state health departments and other reporting agencies. CPSC and 
several state attorney generals across the country recently convened a joint meeting to explore
collaborative strategies to improve the enforcement of lead limits in the United States.
CPSC is continuing to send letters or issue press releases to notify foreign countries or
counterparts when products have been recalled or recalled products that violate lead standards 
have been distributed.  CPSC welcome reports from CDC, its partners and grantees at state 
and local levels, and other concerned parties about any products distributed in the United States
that violate lead limit standards.  CPSC will continue to aggressively pursue and investigate 
laboratory findings from lead testing of products that demonstrate violations of lead standards.
Four, CPSC expects testing and certification to be tremendous enforcement tools after these 
requirements become effective in February 2010.  Importers and manufacturers will be required 
to certify that their products are in compliance with CPSIA based on a testing program.  Under 
CPSIA, CPSC will be authorized to issue civil penalties to any importer or manufacturer that 
submits a false certification of a product.
Five, CPSC requires self-reporting within 24 hours of products that “might” violate CPSC bans
and standards or “might” pose a substantial hazard to consumers.  For extremely complex
situations, however, CPSC will allow the reporting firm to self-report in ten days.  CPSC’s 
award-winning Fast Track Recall Program has been extremely effective in removing dangerous 
products from the marketplace and enforcing lead limits.
Mr. Howsare reported that CPSC increased education and training to foreign government
officials and suppliers after CPSIA was passed to ensure compliance with lead limits and other 
regulations.  CPSC recently installed new video conferencing software to facilitate broadcasts of
webcasts, webinars and training seminars in two languages simultaneously without the need for 
staff to travel overseas and overcome language barriers.  However, CPSC still deploys staff 
overseas on a regular basis to train and educate foreign officials and suppliers on the
importance of complying with U.S. lead laws and other consumer product safety regulations.
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CPSC posts all guidance documents on its website in Mandarin and Vietnamese to eliminate 
the need for China and Vietnam to translate CPSC documents.  CPSC outreaches to importers
and foreign suppliers to facilitate compliance with lead limits and other CPSIA requirements. 
CPSC will develop and distribute a handbook to importers within the next year and continues to
disseminate a handbook to small businesses and resellers.  CPSC hopes to create and provide
hand crafters with a similar handbook in the near future.  CPSC will continue to participate in
official meetings with foreign government officials and various economies to emphasize the 
critical need for compliance with U.S. lead laws and other consumer product safety regulations.
CPSC leadership and senior management are currently attending the U.S./China Consumer
Product Safety Summit to discuss compliance with the new CPSIA lead limits and other 
requirements. The Lead in Children’s Products Workgroup is one of six workgroups that will be
convened during the summit.  The workgroup will focus on lead in toys, identify concrete steps 
to take at the regulatory expert level, and advance full compliance with CPSIA lead limits.
Action steps developed by the workgroup are expected to target production, testing, certification
and enforcement practices. 
CPSC has focused its domestic educational activities on ensuring that manufacturers comply 
with CPSIA’s new lead limits and informing consumers of the new lead laws.  CPSC now utilizes 
Face Book, Twitter, Flicker and other social media outlets to widely publicize its consumer
product safety messages and rapidly inform the public about dangerous products that have 
been recalled. 
CPSC convenes public meetings and broadcasts webinars to engage consumers in dialogue
and provide education on complying with the new lead limits.  CPSC’s website and recalls of
dangerous products in the marketplace also serve as effective educational tools.  CPSC is
holding Public Commission hearings to more actively engage stakeholders in the regulatory
process and reinforce its educational messages.
The CPSC Chairman has expressed a strong desire to convene a full Commission hearing on
childhood lead poisoning prevention to publicize the dangers of lead to children.  Mr. Howsare 
encouraged the ACCLPP members to attend the hearing and make a presentation to the full
Commission.  He emphasized that ACCLPP’s subject-matter expertise during the hearing would
be extremely beneficial to Commissioners who have an interest in learning more about lead in 
consumer products and childhood lead poisoning prevention. 
Mr. Howsare conveyed that CPSC has planned several activities in the future to strengthen 
compliance with and education of CPSIA regulations.  Most notably, CPSC will respond to three 
recommendations the U.S. Government Accountability Office recently issued related to CPSC’s 
Import Surveillance Program.
CPSC was advised to quickly implement CPSIA requirements for imports by developing a 
substantial products hazards/generic defects list and creating import risk strategies in
collaboration with U.S. Customs and Border Protection (CBP).  CPSC is partnering with CBP to
develop these strategies and also is undergoing the rule-making process to prevent the import
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at U.S. ports of entry of drawstrings on children’s outerwear and other generic defects that pose 
a risk.
CPSC was advised to take action on targeting shipments, including updating information 
sharing agreements with CBP and ensuring a presence at the CBP Targeting Center.  CPSC
has completed both of these activities. CPSC was advised to update its strategic plan with
import strategies. CPSC expects to begin responding to this recommendation within the next 
few weeks. 
CPSC’s other future activities include enforcement of CPSIA testing and certification
requirements to further promote lead poisoning prevention.  CPSC will launch a new public
database over the next 18 months to enhance the collection of information on potentially 
dangerous products. CPSC will partner with industry, consumer groups and other stakeholders 
to ensure the accuracy of information that is submitted. 
After the database is launched, CPSC will convene a series of meetings with stakeholders from 
multiple sectors, including industry, consumer groups, and federal and state agencies, to ensure
the data are effectively used and widely disseminated to protect consumers.  CPSC also will
use software that will mine information from the database to identify problematic products, 
patterns, trends and emerging hazards. 
Dr. Brown noted that CPSC uses the handheld XRF to test products for lead at U.S. ports.
However, data have shown a strong correlation between this device and false-negative results 
or non-detectable limits even for products with high lead levels.  She offered to collaborate with
CPSC on developing more effective methods to test products for lead at ports. 
Dr. Brown conveyed that CDC-funded CLPPPs have informed CDC of their difficulties over a
number of years in attempting to navigate and access CPSC’s cumbersome reporting process.
She offered the services of Ms. Samantha Harrykisson, of LPPB, to closely collaborate with 
CPSC in streamlining its reporting process for CLPPPs in the field to more easily use this 
system. 
ACCLPP thanked Mr. Howsare for providing an extremely comprehensive and informative
update on CPSC’s lead poisoning prevention strategies.  The ACCLPP members looked
forward to additional reports on CPSC’s ongoing and future activities and also welcomed the 
opportunity to provide assistance and guidance to advance these efforts, particularly during the 
upcoming Commission hearing on childhood lead poisoning prevention. 
ACCLPP Business Session 
Dr. Brown noted that EIWG’s draft charge was distributed to ACCLPP for review, discussion
and a formal vote. [Editor’s Note:  Due to ACCLPP’s upcoming vote on this issue, the draft 
charge reflects no editorial changes and is captured below as read verbatim into the record by 
Dr. Gardner.]
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 “The Educational Interventions for Lead-Exposed Children Work Group, in conjunction with 
the committee, will implement the following charges as provided by the ACCLPPP during 
the March 2008 meeting and as further discussed during the October 2008 meeting: 
Compile existing evidence; Review IDEA parts B and C, Special Education and model 
regulations to provide guidance to state and local governments; and describe specific action 
steps for parents, clinicians and educators.
 To implement the committee charges, the workgroup will focus on the following activities: (1)
make recommendations regarding developmental assessment, intervention and special 
education services for children with elevated blood lead levels; (2) inventory the existing
regulatory and policies that support provision of assessment and educational interventions 
and mechanisms for ensuring that children with a history of elevated blood lead levels 
receive the services they are entitled to; (3) provide guidance to state and local 
governments, parents, pediatric health care providers, lead poisoning prevention programs,
educators, and others who work with young children. The work group, in conjunction with 
the committee, will make a summary of the recommendations for publication.” 
A motion was properly placed on the floor and seconded by Ms. Kite and Mr. Williams,
respectively, to accept the Educational Intervention Workgroup charge with ACCLPP’s two
suggested revisions:  change “inventory” to “review” and “regulatory” to “regulations.” ACCLPP
unanimously approved the motion with the changes noted for the record. There was no
further discussion.
Dr. Brown returned to LCPWG’s draft charge Dr. Kosnett read into the record on the previous
day. ACCLPP made three key suggestions that should be considered in LCPWG’s ongoing 
activities and future direction.
 LCPWG’s draft charge should be revised to more broadly focus on “developing
countries” rather than specifically focusing on China. 
 LCPWG should be charged with investigating and posting lead-containing consumer 
products of concern on the CDC website with oversight by ACCLPP.
 LCPWG should use the international conference to form an ongoing global partnership
to maintain long-term momentum on lead in consumer products.
A motion was properly placed on the floor and seconded by Drs. Sandel and Reyes,
respectively, to accept the Lead in Consumer Products Workgroup charge.  ACCLPP
unanimously approved the motion.  Dr. Brown confirmed that ACCLPP’s suggestions on
LCPWG’s proposed charge would be taken into consideration.
Public Comment Session 
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Mr. Boreiko noted that the International Organization for Standardization Secretariat issues
standards, particularly for items containing lead.  These products include food, contact surfaces,
crystal, ceramic ware, PVC and water pipes.  He pointed out that the European Union has been
extremely attentive to issues related to these products.
Mr. Boreiko announced that the European Union is currently revising occupational exposure 
standards in collaboration with industry and ILZRO. He hoped CDC would make the draft 
version of the lead and pregnancy paper available in the near future to inform this process.
Closing Session 
The participants joined Dr. Rhoads in applauding Mr. Barry Brooks, Ms. Claudine Johnson, and 
other CDC staff and contractors for providing outstanding administrative support and making
logistical arrangements for the ACCLPP meeting.  He announced that the next ACCLPP
meeting would be held on March 18-19, 2010 in Atlanta, Georgia. 
Dr. Brown thanked the ACCLPP members for their continued energy, commitment and support
to childhood lead poisoning and healthy homes.
With no further discussion or business brought before ACCLPP, Dr. Rhoads adjourned the
meeting at 12:20 p.m. on October 22, 2009. 
I hereby certify that to the best of my 
knowledge, the foregoing Minutes of the 
proceedings are accurate and complete. 
_1/11/2010_________ _________________________________ 
Date       George G. Rhoads, M.D., M.P.H.
       Chair, Advisory Committee on 
       Childhood Lead Poisoning Prevention 
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